http://2012.igem.org/wiki/index.php?title=Team:Slovenia/SocietyMedicalDoctors&feed=atom&action=historyTeam:Slovenia/SocietyMedicalDoctors - Revision history2024-03-29T15:41:06ZRevision history for this page on the wikiMediaWiki 1.16.0http://2012.igem.org/wiki/index.php?title=Team:Slovenia/SocietyMedicalDoctors&diff=289546&oldid=prevUrbanB at 20:53, 26 October 20122012-10-26T20:53:34Z<p></p>
<table style="background-color: white; color:black;">
<col class='diff-marker' />
<col class='diff-content' />
<col class='diff-marker' />
<col class='diff-content' />
<tr valign='top'>
<td colspan='2' style="background-color: white; color:black;">← Older revision</td>
<td colspan='2' style="background-color: white; color:black;">Revision as of 20:53, 26 October 2012</td>
</tr><tr><td colspan="2" class="diff-lineno">Line 2:</td>
<td colspan="2" class="diff-lineno">Line 2:</td></tr>
<tr><td class='diff-marker'> </td><td style="background: #eee; color:black; font-size: smaller;"><div><head></div></td><td class='diff-marker'> </td><td style="background: #eee; color:black; font-size: smaller;"><div><head></div></td></tr>
<tr><td class='diff-marker'> </td><td style="background: #eee; color:black; font-size: smaller;"><div><meta http-equiv="X-UA-Compatible" content="IE=edge" /></div></td><td class='diff-marker'> </td><td style="background: #eee; color:black; font-size: smaller;"><div><meta http-equiv="X-UA-Compatible" content="IE=edge" /></div></td></tr>
<tr><td colspan="2"> </td><td class='diff-marker'>+</td><td style="background: #cfc; color:black; font-size: smaller;"><div><ins style="color: red; font-weight: bold; text-decoration: none;"><!-- back to top --></ins></div></td></tr>
<tr><td colspan="2"> </td><td class='diff-marker'>+</td><td style="background: #cfc; color:black; font-size: smaller;"><div><ins style="color: red; font-weight: bold; text-decoration: none;"><div style="position:fixed; bottom:45px; right:30px; width:100px; height:66px; background-color:transparent;"></ins></div></td></tr>
<tr><td colspan="2"> </td><td class='diff-marker'>+</td><td style="background: #cfc; color:black; font-size: smaller;"><div><ins style="color: red; font-weight: bold; text-decoration: none;"><a href="#topofthepage"></ins></div></td></tr>
<tr><td colspan="2"> </td><td class='diff-marker'>+</td><td style="background: #cfc; color:black; font-size: smaller;"><div><ins style="color: red; font-weight: bold; text-decoration: none;"><table style="background-color:transparent;" onclick="window.location = '#topofthepage'" class="invisible" style="height:100%;"></ins></div></td></tr>
<tr><td colspan="2"> </td><td class='diff-marker'>+</td><td style="background: #cfc; color:black; font-size: smaller;"><div><ins style="color: red; font-weight: bold; text-decoration: none;"><tr class="invisible" style="background-color:transparent;"></ins></div></td></tr>
<tr><td colspan="2"> </td><td class='diff-marker'>+</td><td style="background: #cfc; color:black; font-size: smaller;"><div><ins style="color: red; font-weight: bold; text-decoration: none;"><td class="invisible" style="background-color:transparent;" valign="center"></ins></div></td></tr>
<tr><td colspan="2"> </td><td class='diff-marker'>+</td><td style="background: #cfc; color:black; font-size: smaller;"><div><ins style="color: red; font-weight: bold; text-decoration: none;"><img width="100px" src ="https://static.igem.org/mediawiki/2012/1/14/Svn12_hp_btt.png"></img></ins></div></td></tr>
<tr><td colspan="2"> </td><td class='diff-marker'>+</td><td style="background: #cfc; color:black; font-size: smaller;"><div><ins style="color: red; font-weight: bold; text-decoration: none;"></td></tr></table></ins></div></td></tr>
<tr><td colspan="2"> </td><td class='diff-marker'>+</td><td style="background: #cfc; color:black; font-size: smaller;"><div><ins style="color: red; font-weight: bold; text-decoration: none;"></a></ins></div></td></tr>
<tr><td colspan="2"> </td><td class='diff-marker'>+</td><td style="background: #cfc; color:black; font-size: smaller;"><div><ins style="color: red; font-weight: bold; text-decoration: none;"></div></ins></div></td></tr>
<tr><td class='diff-marker'> </td><td style="background: #eee; color:black; font-size: smaller;"></td><td class='diff-marker'> </td><td style="background: #eee; color:black; font-size: smaller;"></td></tr>
<tr><td class='diff-marker'> </td><td style="background: #eee; color:black; font-size: smaller;"><div><style type="text/css"></div></td><td class='diff-marker'> </td><td style="background: #eee; color:black; font-size: smaller;"><div><style type="text/css"></div></td></tr>
<tr><td colspan="2" class="diff-lineno">Line 313:</td>
<td colspan="2" class="diff-lineno">Line 323:</td></tr>
<tr><td class='diff-marker'> </td><td style="background: #eee; color:black; font-size: smaller;"></td><td class='diff-marker'> </td><td style="background: #eee; color:black; font-size: smaller;"></td></tr>
<tr><td class='diff-marker'> </td><td style="background: #eee; color:black; font-size: smaller;"><div><body></div></td><td class='diff-marker'> </td><td style="background: #eee; color:black; font-size: smaller;"><div><body></div></td></tr>
<tr><td colspan="2"> </td><td class='diff-marker'>+</td><td style="background: #cfc; color:black; font-size: smaller;"><div><ins style="color: red; font-weight: bold; text-decoration: none;"><a name="topofthepage" style="background-color:transparent;"></a></ins></div></td></tr>
<tr><td colspan="2"> </td><td class='diff-marker'>+</td><td style="background: #cfc; color:black; font-size: smaller;"><div><ins style="color: red; font-weight: bold; text-decoration: none;"></ins></div></td></tr>
<tr><td class='diff-marker'> </td><td style="background: #eee; color:black; font-size: smaller;"><div><div id="banner"></div></td><td class='diff-marker'> </td><td style="background: #eee; color:black; font-size: smaller;"><div><div id="banner"></div></td></tr>
<tr><td class='diff-marker'> </td><td style="background: #eee; color:black; font-size: smaller;"><div></div></div></td><td class='diff-marker'> </td><td style="background: #eee; color:black; font-size: smaller;"><div></div></div></td></tr>
<tr><td colspan="2" class="diff-lineno">Line 336:</td>
<td colspan="2" class="diff-lineno">Line 348:</td></tr>
<tr><td class='diff-marker'> </td><td style="background: #eee; color:black; font-size: smaller;"><div> <li><a href='https://2012.igem.org/Team:Slovenia/TheSwitchDesignedTALregulators'><span>Designed TAL regulators</span></a></li></div></td><td class='diff-marker'> </td><td style="background: #eee; color:black; font-size: smaller;"><div> <li><a href='https://2012.igem.org/Team:Slovenia/TheSwitchDesignedTALregulators'><span>Designed TAL regulators</span></a></li></div></td></tr>
<tr><td class='diff-marker'> </td><td style="background: #eee; color:black; font-size: smaller;"><div> <li><a href='https://2012.igem.org/Team:Slovenia/TheSwitchMutualRepressorSwitch'><span>Mutual repressor switch</span></a></li> </div></td><td class='diff-marker'> </td><td style="background: #eee; color:black; font-size: smaller;"><div> <li><a href='https://2012.igem.org/Team:Slovenia/TheSwitchMutualRepressorSwitch'><span>Mutual repressor switch</span></a></li> </div></td></tr>
<tr><td class='diff-marker'>-</td><td style="background: #ffa; color:black; font-size: smaller;"><div> <li><a href='https://2012.igem.org/Team:Slovenia/TheSwitchPositiveFeedbackLoopSwitch'><table class="newtable"><tr class="newtable"><td class="newtable"><span>Positive feedback loop switch</span></td><td class="newtable"><img style="margin-right:-15px;" width="25px" src="https://static.igem.org/mediawiki/2012/e/ee/Svn12_hp_new.png"></img></td></tr></table></a></li></div></td><td class='diff-marker'>+</td><td style="background: #cfc; color:black; font-size: smaller;"><div> <li><a href='https://2012.igem.org/Team:Slovenia/TheSwitchPositiveFeedbackLoopSwitch'><table <ins class="diffchange diffchange-inline">onclick="window.location = 'https://2012.igem.org/Team:Slovenia/TheSwitchPositiveFeedbackLoopSwitch';" </ins>class="newtable"><tr class="newtable"><td class="newtable"><span>Positive feedback loop switch</span></td><td class="newtable"><img style="margin-right:-15px;" width="25px" src="https://static.igem.org/mediawiki/2012/e/ee/Svn12_hp_new.png"></img></td></tr></table></a></li></div></td></tr>
<tr><td class='diff-marker'>-</td><td style="background: #ffa; color:black; font-size: smaller;"><div> <li><a href='https://2012.igem.org/Team:Slovenia/TheSwitchControls'><table class="newtable"><tr class="newtable"><td class="newtable"><span>Controls</span></td><td class="newtable"><img style="margin-right:-81px;" width="25px" src="https://static.igem.org/mediawiki/2012/e/ee/Svn12_hp_new.png"></img></td></tr></table></a></li> </div></td><td class='diff-marker'>+</td><td style="background: #cfc; color:black; font-size: smaller;"><div> <li><a href='https://2012.igem.org/Team:Slovenia/TheSwitchControls'><table <ins class="diffchange diffchange-inline">onclick="window.location = 'https://2012.igem.org/Team:Slovenia/TheSwitchControls';" </ins>class="newtable"><tr class="newtable"><td class="newtable"><span>Controls</span></td><td class="newtable"><img style="margin-right:-81px;" width="25px" src="https://static.igem.org/mediawiki/2012/e/ee/Svn12_hp_new.png"></img></td></tr></table></a></li> </div></td></tr>
<tr><td class='diff-marker'> </td><td style="background: #eee; color:black; font-size: smaller;"><div> </ul></div></td><td class='diff-marker'> </td><td style="background: #eee; color:black; font-size: smaller;"><div> </ul></div></td></tr>
<tr><td class='diff-marker'> </td><td style="background: #eee; color:black; font-size: smaller;"><div> </li></div></td><td class='diff-marker'> </td><td style="background: #eee; color:black; font-size: smaller;"><div> </li></div></td></tr>
<tr><td colspan="2" class="diff-lineno">Line 345:</td>
<td colspan="2" class="diff-lineno">Line 357:</td></tr>
<tr><td class='diff-marker'> </td><td style="background: #eee; color:black; font-size: smaller;"><div> <li><a href='https://2012.igem.org/Team:Slovenia/SafetyMechanismsEscapeTag'><span>Escape tag</span></a></li> </div></td><td class='diff-marker'> </td><td style="background: #eee; color:black; font-size: smaller;"><div> <li><a href='https://2012.igem.org/Team:Slovenia/SafetyMechanismsEscapeTag'><span>Escape tag</span></a></li> </div></td></tr>
<tr><td class='diff-marker'> </td><td style="background: #eee; color:black; font-size: smaller;"><div> <li><a href='https://2012.igem.org/Team:Slovenia/SafetyMechanismsTermination'><span>Termination</span></a></li> </div></td><td class='diff-marker'> </td><td style="background: #eee; color:black; font-size: smaller;"><div> <li><a href='https://2012.igem.org/Team:Slovenia/SafetyMechanismsTermination'><span>Termination</span></a></li> </div></td></tr>
<tr><td class='diff-marker'>-</td><td style="background: #ffa; color:black; font-size: smaller;"><div> <li><a href=<del class="diffchange diffchange-inline">'</del>https://2012.igem.org/Team:Slovenia/SafetyMechanismsMicrocapsuleDegradation<del class="diffchange diffchange-inline">'</del>><table class="newtable"><tr class="newtable"><td class="newtable"><span>Microcapsule degradation</span></td><td class="newtable"><img style="margin-right:-15px;" width="25px" src="https://static.igem.org/mediawiki/2012/e/ee/Svn12_hp_new.png"></img></td></tr></table></a></li> </div></td><td class='diff-marker'>+</td><td style="background: #cfc; color:black; font-size: smaller;"><div> <li><a href=<ins class="diffchange diffchange-inline">"</ins>https://2012.igem.org/Team:Slovenia/SafetyMechanismsMicrocapsuleDegradation<ins class="diffchange diffchange-inline">"</ins>><table <ins class="diffchange diffchange-inline"> onclick="window.location = 'https://2012.igem.org/Team:Slovenia/SafetyMechanismsMicrocapsuleDegradation';" </ins>class="newtable"><tr class="newtable"><td class="newtable"><span>Microcapsule degradation</span></td><td class="newtable"><img style="margin-right:-15px;" width="25px" src="https://static.igem.org/mediawiki/2012/e/ee/Svn12_hp_new.png"></img></td></tr></table></a></li> </div></td></tr>
<tr><td class='diff-marker'> </td><td style="background: #eee; color:black; font-size: smaller;"><div> </ul></div></td><td class='diff-marker'> </td><td style="background: #eee; color:black; font-size: smaller;"><div> </ul></div></td></tr>
<tr><td class='diff-marker'> </td><td style="background: #eee; color:black; font-size: smaller;"><div> </li></div></td><td class='diff-marker'> </td><td style="background: #eee; color:black; font-size: smaller;"><div> </li></div></td></tr>
<tr><td colspan="2" class="diff-lineno">Line 353:</td>
<td colspan="2" class="diff-lineno">Line 365:</td></tr>
<tr><td class='diff-marker'> </td><td style="background: #eee; color:black; font-size: smaller;"><div> <li><a href='https://2012.igem.org/Team:Slovenia/ImplementationHepatitisC'><span>Hepatitis C</span></a></li></div></td><td class='diff-marker'> </td><td style="background: #eee; color:black; font-size: smaller;"><div> <li><a href='https://2012.igem.org/Team:Slovenia/ImplementationHepatitisC'><span>Hepatitis C</span></a></li></div></td></tr>
<tr><td class='diff-marker'> </td><td style="background: #eee; color:black; font-size: smaller;"><div> <li><a href='https://2012.igem.org/Team:Slovenia/ImplementationIschaemicHeartDisease'><span>Ischaemic heart disease</span></a></li> </div></td><td class='diff-marker'> </td><td style="background: #eee; color:black; font-size: smaller;"><div> <li><a href='https://2012.igem.org/Team:Slovenia/ImplementationIschaemicHeartDisease'><span>Ischaemic heart disease</span></a></li> </div></td></tr>
<tr><td class='diff-marker'>-</td><td style="background: #ffa; color:black; font-size: smaller;"><div> <li><a href='https://2012.igem.org/Team:Slovenia/ImplementationImpact'><table class="newtable"><tr class="newtable"><td class="newtable"><span>Impact</span></td><td class="newtable"><img style="margin-right:-86px;" width="25px" src="https://static.igem.org/mediawiki/2012/e/ee/Svn12_hp_new.png"></img></td></tr></table></a></li> </div></td><td class='diff-marker'>+</td><td style="background: #cfc; color:black; font-size: smaller;"><div> <li><a href='https://2012.igem.org/Team:Slovenia/ImplementationImpact'><table <ins class="diffchange diffchange-inline">onclick="window.location = 'https://2012.igem.org/Team:Slovenia/ImplementationImpact';" </ins>class="newtable"><tr class="newtable"><td class="newtable"><span>Impact</span></td><td class="newtable"><img style="margin-right:-86px;" width="25px" src="https://static.igem.org/mediawiki/2012/e/ee/Svn12_hp_new.png"></img></td></tr></table></a></li> </div></td></tr>
<tr><td class='diff-marker'> </td><td style="background: #eee; color:black; font-size: smaller;"><div> </div></td><td class='diff-marker'> </td><td style="background: #eee; color:black; font-size: smaller;"><div> </div></td></tr>
<tr><td class='diff-marker'> </td><td style="background: #eee; color:black; font-size: smaller;"><div> </ul></div></td><td class='diff-marker'> </td><td style="background: #eee; color:black; font-size: smaller;"><div> </ul></div></td></tr>
<tr><td colspan="2" class="diff-lineno">Line 361:</td>
<td colspan="2" class="diff-lineno">Line 373:</td></tr>
<tr><td class='diff-marker'> </td><td style="background: #eee; color:black; font-size: smaller;"><div> <ul></div></td><td class='diff-marker'> </td><td style="background: #eee; color:black; font-size: smaller;"><div> <ul></div></td></tr>
<tr><td class='diff-marker'> </td><td style="background: #eee; color:black; font-size: smaller;"><div> <li><a href='https://2012.igem.org/Team:Slovenia/Modeling'><span>Overview</span></a></li></div></td><td class='diff-marker'> </td><td style="background: #eee; color:black; font-size: smaller;"><div> <li><a href='https://2012.igem.org/Team:Slovenia/Modeling'><span>Overview</span></a></li></div></td></tr>
<tr><td class='diff-marker'>-</td><td style="background: #ffa; color:black; font-size: smaller;"><div> <li><a href='https://2012.igem.org/Team:Slovenia/ModelingPK'><table class="newtable"><tr class="newtable"><td class="newtable"><span>Pharmacokinetics</span></td><td class="newtable"><img style="margin-right:-15px;" width="25px" src="https://static.igem.org/mediawiki/2012/e/ee/Svn12_hp_new.png"></img></td></tr></table></a></li> </div></td><td class='diff-marker'>+</td><td style="background: #cfc; color:black; font-size: smaller;"><div> <li><a href='https://2012.igem.org/Team:Slovenia/ModelingPK'><table <ins class="diffchange diffchange-inline">onclick="window.location = 'https://2012.igem.org/Team:Slovenia/ModelingPK';" </ins>class="newtable"><tr class="newtable"><td class="newtable"><span>Pharmacokinetics</span></td><td class="newtable"><img style="margin-right:-15px;" width="25px" src="https://static.igem.org/mediawiki/2012/e/ee/Svn12_hp_new.png"></img></td></tr></table></a></li> </div></td></tr>
<tr><td class='diff-marker'> </td><td style="background: #eee; color:black; font-size: smaller;"><div> <li><a href='https://2012.igem.org/Team:Slovenia/ModelingMethods'><span>Modeling methods</span></a></li></div></td><td class='diff-marker'> </td><td style="background: #eee; color:black; font-size: smaller;"><div> <li><a href='https://2012.igem.org/Team:Slovenia/ModelingMethods'><span>Modeling methods</span></a></li></div></td></tr>
<tr><td class='diff-marker'> </td><td style="background: #eee; color:black; font-size: smaller;"><div> <li><a href='https://2012.igem.org/Team:Slovenia/ModelingMutualRepressorSwitch'><span>Mutual repressor switch</span></a></li></div></td><td class='diff-marker'> </td><td style="background: #eee; color:black; font-size: smaller;"><div> <li><a href='https://2012.igem.org/Team:Slovenia/ModelingMutualRepressorSwitch'><span>Mutual repressor switch</span></a></li></div></td></tr>
<tr><td class='diff-marker'> </td><td style="background: #eee; color:black; font-size: smaller;"><div> <li><a href='https://2012.igem.org/Team:Slovenia/ModelingPositiveFeedbackLoopSwitch'><span>Positive feedback loop switch</span></a></li> </div></td><td class='diff-marker'> </td><td style="background: #eee; color:black; font-size: smaller;"><div> <li><a href='https://2012.igem.org/Team:Slovenia/ModelingPositiveFeedbackLoopSwitch'><span>Positive feedback loop switch</span></a></li> </div></td></tr>
<tr><td class='diff-marker'>-</td><td style="background: #ffa; color:black; font-size: smaller;"><div> <li><a href='https://2012.igem.org/Team:Slovenia/ModelingQuantitativeModel'><table class="newtable"><tr class="newtable"><td class="newtable"><span>Experimental model</span></td><td class="newtable"><img style="margin-right:-15px;" width="25px" src="https://static.igem.org/mediawiki/2012/e/ee/Svn12_hp_new.png"></img></td></tr></table></a></li> </div></td><td class='diff-marker'>+</td><td style="background: #cfc; color:black; font-size: smaller;"><div> <li><a href='https://2012.igem.org/Team:Slovenia/ModelingQuantitativeModel'><table <ins class="diffchange diffchange-inline">onclick="window.location = 'https://2012.igem.org/Team:Slovenia/ModelingQuantitativeModel';" </ins>class="newtable"><tr class="newtable"><td class="newtable"><span>Experimental model</span></td><td class="newtable"><img style="margin-right:-15px;" width="25px" src="https://static.igem.org/mediawiki/2012/e/ee/Svn12_hp_new.png"></img></td></tr></table></a></li> </div></td></tr>
<tr><td class='diff-marker'>-</td><td style="background: #ffa; color:black; font-size: smaller;"><div> <li><a href='https://2012.igem.org/Team:Slovenia/ModelingInteractiveSimulations'><table class="newtable"><tr class="newtable"><td class="newtable"><span>Interactive simulations</span></td><td class="newtable"><img style="margin-right:-15px;" width="25px" src="https://static.igem.org/mediawiki/2012/e/ee/Svn12_hp_new.png"></img></td></tr></table></a></li> </div></td><td class='diff-marker'>+</td><td style="background: #cfc; color:black; font-size: smaller;"><div> <li><a href='https://2012.igem.org/Team:Slovenia/ModelingInteractiveSimulations'><table <ins class="diffchange diffchange-inline">onclick="window.location = 'https://2012.igem.org/Team:Slovenia/ModelingInteractiveSimulations';" </ins>class="newtable"><tr class="newtable"><td class="newtable"><span>Interactive simulations</span></td><td class="newtable"><img style="margin-right:-15px;" width="25px" src="https://static.igem.org/mediawiki/2012/e/ee/Svn12_hp_new.png"></img></td></tr></table></a></li> </div></td></tr>
<tr><td class='diff-marker'> </td><td style="background: #eee; color:black; font-size: smaller;"><div> </ul></div></td><td class='diff-marker'> </td><td style="background: #eee; color:black; font-size: smaller;"><div> </ul></div></td></tr>
<tr><td class='diff-marker'> </td><td style="background: #eee; color:black; font-size: smaller;"><div> </li></div></td><td class='diff-marker'> </td><td style="background: #eee; color:black; font-size: smaller;"><div> </li></div></td></tr>
<tr><td colspan="2" class="diff-lineno">Line 377:</td>
<td colspan="2" class="diff-lineno">Line 389:</td></tr>
<tr><td class='diff-marker'> </td><td style="background: #eee; color:black; font-size: smaller;"><div> <ul></div></td><td class='diff-marker'> </td><td style="background: #eee; color:black; font-size: smaller;"><div> <ul></div></td></tr>
<tr><td class='diff-marker'> </td><td style="background: #eee; color:black; font-size: smaller;"><div> <li><a href='https://2012.igem.org/Team:Slovenia/Notebook'><span>Experimental methods</span></a></li></div></td><td class='diff-marker'> </td><td style="background: #eee; color:black; font-size: smaller;"><div> <li><a href='https://2012.igem.org/Team:Slovenia/Notebook'><span>Experimental methods</span></a></li></div></td></tr>
<tr><td class='diff-marker'>-</td><td style="background: #ffa; color:black; font-size: smaller;"><div> <li><a href='https://2012.igem.org/Team:Slovenia/NotebookLablog'><table class="newtable"><tr class="newtable"><td class="newtable"><span>Lablog</span></td><td class="newtable"><img style="margin-right:-90px;" width="25px" src="https://static.igem.org/mediawiki/2012/e/ee/Svn12_hp_new.png"></img></td></tr></table></a></li> </div></td><td class='diff-marker'>+</td><td style="background: #cfc; color:black; font-size: smaller;"><div> <li><a href='https://2012.igem.org/Team:Slovenia/NotebookLablog'><table <ins class="diffchange diffchange-inline">onclick="window.location = 'https://2012.igem.org/Team:Slovenia/NotebookLablog';" </ins>class="newtable"><tr class="newtable"><td class="newtable"><span>Lablog</span></td><td class="newtable"><img style="margin-right:-90px;" width="25px" src="https://static.igem.org/mediawiki/2012/e/ee/Svn12_hp_new.png"></img></td></tr></table></a></li> </div></td></tr>
<tr><td class='diff-marker'> </td><td style="background: #eee; color:black; font-size: smaller;"><div> <li><a href='https://2012.igem.org/Team:Slovenia/NotebookLabSafety'><span>Lab safety</span></a></li> </div></td><td class='diff-marker'> </td><td style="background: #eee; color:black; font-size: smaller;"><div> <li><a href='https://2012.igem.org/Team:Slovenia/NotebookLabSafety'><span>Lab safety</span></a></li> </div></td></tr>
<tr><td class='diff-marker'> </td><td style="background: #eee; color:black; font-size: smaller;"><div> </ul></div></td><td class='diff-marker'> </td><td style="background: #eee; color:black; font-size: smaller;"><div> </ul></div></td></tr>
<tr><td colspan="2" class="diff-lineno">Line 400:</td>
<td colspan="2" class="diff-lineno">Line 412:</td></tr>
<tr><td class='diff-marker'> </td><td style="background: #eee; color:black; font-size: smaller;"><div> <li><a href='https://2012.igem.org/Team:Slovenia/Team'><span>Team members</span></a></li></div></td><td class='diff-marker'> </td><td style="background: #eee; color:black; font-size: smaller;"><div> <li><a href='https://2012.igem.org/Team:Slovenia/Team'><span>Team members</span></a></li></div></td></tr>
<tr><td class='diff-marker'> </td><td style="background: #eee; color:black; font-size: smaller;"><div> <li><a href='https://2012.igem.org/Team:Slovenia/TeamAttributions'><span>Attributions</span></a></li></div></td><td class='diff-marker'> </td><td style="background: #eee; color:black; font-size: smaller;"><div> <li><a href='https://2012.igem.org/Team:Slovenia/TeamAttributions'><span>Attributions</span></a></li></div></td></tr>
<tr><td class='diff-marker'>-</td><td style="background: #ffa; color:black; font-size: smaller;"><div> <li><a href='https://2012.igem.org/Team:Slovenia/TeamCollaborations'><table class="newtable"><tr class="newtable"><td class="newtable"><span>Collaborations</span></td><td class="newtable"><img style="margin-right:-20px;" width="25px" src="https://static.igem.org/mediawiki/2012/e/ee/Svn12_hp_new.png"></img></td></tr></table></a></li></div></td><td class='diff-marker'>+</td><td style="background: #cfc; color:black; font-size: smaller;"><div> <li><a href='https://2012.igem.org/Team:Slovenia/TeamCollaborations'><table <ins class="diffchange diffchange-inline"> onclick="window.location = 'https://2012.igem.org/Team:Slovenia/TeamCollaborations';" </ins>class="newtable"><tr class="newtable"><td class="newtable"><span>Collaborations</span></td><td class="newtable"><img style="margin-right:-20px;" width="25px" src="https://static.igem.org/mediawiki/2012/e/ee/Svn12_hp_new.png"></img></td></tr></table></a></li></div></td></tr>
<tr><td class='diff-marker'> </td><td style="background: #eee; color:black; font-size: smaller;"><div> <li><a href='https://2012.igem.org/Team:Slovenia/TeamGallery'><span>Gallery</span></a></li> </div></td><td class='diff-marker'> </td><td style="background: #eee; color:black; font-size: smaller;"><div> <li><a href='https://2012.igem.org/Team:Slovenia/TeamGallery'><span>Gallery</span></a></li> </div></td></tr>
<tr><td class='diff-marker'> </td><td style="background: #eee; color:black; font-size: smaller;"><div> <li><a href='https://2012.igem.org/Team:Slovenia/TeamSponsors'><span>Sponsors</span></a></li> </div></td><td class='diff-marker'> </td><td style="background: #eee; color:black; font-size: smaller;"><div> <li><a href='https://2012.igem.org/Team:Slovenia/TeamSponsors'><span>Sponsors</span></a></li> </div></td></tr>
<tr><td colspan="2" class="diff-lineno">Line 408:</td>
<td colspan="2" class="diff-lineno">Line 420:</td></tr>
<tr><td class='diff-marker'> </td><td style="background: #eee; color:black; font-size: smaller;"><div> </div></div></td><td class='diff-marker'> </td><td style="background: #eee; color:black; font-size: smaller;"><div> </div></div></td></tr>
<tr><td class='diff-marker'> </td><td style="background: #eee; color:black; font-size: smaller;"><div><!-- end main menu --></div></td><td class='diff-marker'> </td><td style="background: #eee; color:black; font-size: smaller;"><div><!-- end main menu --></div></td></tr>
<tr><td colspan="2"> </td><td class='diff-marker'>+</td><td style="background: #cfc; color:black; font-size: smaller;"><div><ins style="color: red; font-weight: bold; text-decoration: none;"></ins></div></td></tr>
<tr><td class='diff-marker'> </td><td style="background: #eee; color:black; font-size: smaller;"></td><td class='diff-marker'> </td><td style="background: #eee; color:black; font-size: smaller;"></td></tr>
<tr><td class='diff-marker'> </td><td style="background: #eee; color:black; font-size: smaller;"></td><td class='diff-marker'> </td><td style="background: #eee; color:black; font-size: smaller;"></td></tr>
<tr><td colspan="2" class="diff-lineno">Line 419:</td>
<td colspan="2" class="diff-lineno">Line 432:</td></tr>
<tr><td class='diff-marker'> </td><td style="background: #eee; color:black; font-size: smaller;"><div><!-- dummy link na bannerju --></div></td><td class='diff-marker'> </td><td style="background: #eee; color:black; font-size: smaller;"><div><!-- dummy link na bannerju --></div></td></tr>
<tr><td class='diff-marker'> </td><td style="background: #eee; color:black; font-size: smaller;"><div><a href="https://2012.igem.org/Main_Page"></div></td><td class='diff-marker'> </td><td style="background: #eee; color:black; font-size: smaller;"><div><a href="https://2012.igem.org/Main_Page"></div></td></tr>
<tr><td class='diff-marker'>-</td><td style="background: #ffa; color:black; font-size: smaller;"><div><div id="dummy" style="background-color:<del class="diffchange diffchange-inline">white</del>; position:absolute; left:870px; top:25px; width:115px; height:80px; z-index:100; opacity:0.0;"></div></td><td class='diff-marker'>+</td><td style="background: #cfc; color:black; font-size: smaller;"><div><div id="dummy" style="background-color:<ins class="diffchange diffchange-inline">transparent</ins>; position:absolute; left:870px; top:25px; width:115px; height:80px; z-index:100; opacity:0.0;"></div></td></tr>
<tr><td class='diff-marker'> </td><td style="background: #eee; color:black; font-size: smaller;"><div></div></div></td><td class='diff-marker'> </td><td style="background: #eee; color:black; font-size: smaller;"><div></div></div></td></tr>
<tr><td class='diff-marker'> </td><td style="background: #eee; color:black; font-size: smaller;"><div></a></div></td><td class='diff-marker'> </td><td style="background: #eee; color:black; font-size: smaller;"><div></a></div></td></tr>
</table>UrbanBhttp://2012.igem.org/wiki/index.php?title=Team:Slovenia/SocietyMedicalDoctors&diff=282316&oldid=prevUrbanB at 08:17, 26 October 20122012-10-26T08:17:34Z<p></p>
<table style="background-color: white; color:black;">
<col class='diff-marker' />
<col class='diff-content' />
<col class='diff-marker' />
<col class='diff-content' />
<tr valign='top'>
<td colspan='2' style="background-color: white; color:black;">← Older revision</td>
<td colspan='2' style="background-color: white; color:black;">Revision as of 08:17, 26 October 2012</td>
</tr><tr><td colspan="2" class="diff-lineno">Line 526:</td>
<td colspan="2" class="diff-lineno">Line 526:</td></tr>
<tr><td class='diff-marker'> </td><td style="background: #eee; color:black; font-size: smaller;"><div></table></div></td><td class='diff-marker'> </td><td style="background: #eee; color:black; font-size: smaller;"><div></table></div></td></tr>
<tr><td class='diff-marker'> </td><td style="background: #eee; color:black; font-size: smaller;"><div></p><p></div></td><td class='diff-marker'> </td><td style="background: #eee; color:black; font-size: smaller;"><div></p><p></div></td></tr>
<tr><td class='diff-marker'>-</td><td style="background: #ffa; color:black; font-size: smaller;"><div>With respect to the treatment of hepatitis C we thought of three approaches: percutaneus application of capsules into the liver parenchyma, delivery into the peritoneal cavity or delivery via the interventional radiology approach through the portal vein or hepatic artery, a procedure which we discussed with <b>radiologist Peter Popovič, MD, Msc, teaching assistant. </b> Mr. Popovič is the head of the <b>Department for abdominal radiology</b> (Figure 5) <del class="diffchange diffchange-inline">at the Institute of Radiology </del>and specializes in <b>hepatic interventional radiology</b>. We discussed the following approach: a radiologist introduces a catheter into the femoral artery and proceeds via the aorta to the hepatic artery where he injects the suspension of our cells into the blood. The capsules then travel through the arterial tree, getting stuck inside arterioles and capillaries of the liver, remaining there and producing our drug of choice. We got very excited as he went on to say that injecting capsules <b>into the hepatic artery would most likely be possible</b>. He explained that his team carries out these procedures on a daily basis, injecting microspheres (approximately the same size as our capsules) with attached chemoterapeutics into the hepatic artery to target malignant tumors located in the liver parenchyma. To our fear that the capsules would block the blood flow to a significant portion of the liver parenchyma he responded with the fact that the liver gets the majority (80%) of nutrients and oxygen via the portal vein. He added that with the appropriate number of capsules a very small number of vessels would be blocked therefore <b>all of the tissue would be perfused because of collaterals</b>. This led us to our next question about the delivery to an ishemic muscle or the myocardium for <b>the treatment of ishemic heart disease or peripheral arterial disease</b>. Again he responded that an interventional radiology approach may be feasible. Mr. Popovič also mentioned that this approach could be tested on pigs, as mice are too small. He invited us to stay in touch for potential testing of this type of delivery with our microcapsules. Before the meeting we were concerned about not being able to deliver the capsules to the appropriate sites with ease, this meeting, however, filled us with renewed excitement. </p></div></td><td class='diff-marker'>+</td><td style="background: #cfc; color:black; font-size: smaller;"><div>With respect to the treatment of hepatitis C we thought of three approaches: percutaneus application of capsules into the liver parenchyma, delivery into the peritoneal cavity or delivery via the interventional radiology approach through the portal vein or hepatic artery, a procedure which we discussed with <b>radiologist Peter Popovič, MD, Msc, teaching assistant. </b> Mr. Popovič is the head of the <b>Department for abdominal radiology <ins class="diffchange diffchange-inline">at the Institute of Radiology, University Medical Centre Ljubljana</ins></b> (Figure 5) and specializes in <b>hepatic interventional radiology</b>. We discussed the following approach: a radiologist introduces a catheter into the femoral artery and proceeds via the aorta to the hepatic artery where he injects the suspension of our cells into the blood. The capsules then travel through the arterial tree, getting stuck inside arterioles and capillaries of the liver, remaining there and producing our drug of choice. We got very excited as he went on to say that injecting capsules <b>into the hepatic artery would most likely be possible</b>. He explained that his team carries out these procedures on a daily basis, injecting microspheres (approximately the same size as our capsules) with attached chemoterapeutics into the hepatic artery to target malignant tumors located in the liver parenchyma. To our fear that the capsules would block the blood flow to a significant portion of the liver parenchyma he responded with the fact that the liver gets the majority (80%) of nutrients and oxygen via the portal vein. He added that with the appropriate number of capsules a very small number of vessels would be blocked therefore <b>all of the tissue would be perfused because of collaterals</b>. This led us to our next question about the delivery to an ishemic muscle or the myocardium for <b>the treatment of ishemic heart disease or peripheral arterial disease</b>. Again he responded that an interventional radiology approach may be feasible. Mr. Popovič also mentioned that this approach could be tested on pigs, as mice are too small. He invited us to stay in touch for potential testing of this type of delivery with our microcapsules. Before the meeting we were concerned about not being able to deliver the capsules to the appropriate sites with ease, this meeting, however, filled us with renewed excitement. </p></div></td></tr>
<tr><td class='diff-marker'> </td><td style="background: #eee; color:black; font-size: smaller;"><div> </div></td><td class='diff-marker'> </td><td style="background: #eee; color:black; font-size: smaller;"><div> </div></td></tr>
<tr><td class='diff-marker'> </td><td style="background: #eee; color:black; font-size: smaller;"><div><p>In summary, all physicians we contacted thought that the proposed approach offers many advantages and that it would definitely be worthwhile to test it <i>in vivo</i>. </p></div></td><td class='diff-marker'> </td><td style="background: #eee; color:black; font-size: smaller;"><div><p>In summary, all physicians we contacted thought that the proposed approach offers many advantages and that it would definitely be worthwhile to test it <i>in vivo</i>. </p></div></td></tr>
</table>UrbanBhttp://2012.igem.org/wiki/index.php?title=Team:Slovenia/SocietyMedicalDoctors&diff=282298&oldid=prevUrbanB at 08:14, 26 October 20122012-10-26T08:14:22Z<p></p>
<table style="background-color: white; color:black;">
<col class='diff-marker' />
<col class='diff-content' />
<col class='diff-marker' />
<col class='diff-content' />
<tr valign='top'>
<td colspan='2' style="background-color: white; color:black;">← Older revision</td>
<td colspan='2' style="background-color: white; color:black;">Revision as of 08:14, 26 October 2012</td>
</tr><tr><td colspan="2" class="diff-lineno">Line 483:</td>
<td colspan="2" class="diff-lineno">Line 483:</td></tr>
<tr><td class='diff-marker'> </td><td style="background: #eee; color:black; font-size: smaller;"></td><td class='diff-marker'> </td><td style="background: #eee; color:black; font-size: smaller;"></td></tr>
<tr><td class='diff-marker'> </td><td style="background: #eee; color:black; font-size: smaller;"><div><p>We introduced the idea of our project to Prof. Matičič and wanted to know if it could be applicable for the treatment of chronic hepatitis C. We proposed the idea of treating this disease with a combination of the standard therapeutic <b>interferon-alpha</b> and <b>hepatocyte growth factor</b> that would potentially reverse the long term effects of infection on progression to life threatening conditions such as liver cirrhosis and liver cancer that happen in up to 40% of untreated patients or patients unsuccessfully treated with the currently recommended standard of care medications. Her consideration was that something like this has never been done before and so it would be a complete novelty in treating hepatitis C and in her opinion it holds much promise for the future. She also wanted to know about the route of administration of the microcapsules. We considered two possibilities. The first would be a direct application to the liver. She told us this might be possible and that she could organize a meeting with an intervention radiologist, specializing in liver procedures, with whom we made arrangements to discuss this matter further. The other possibility which we considered for administration was to inject the microcapsules into the peritoneal cavity, which could accommodate a larger volume of microcapsules as a mimic of an artificial organ. It turns out intraperitoneal application might be suboptimal because the concentration of therapeutic in the liver would probably be lower.</p></div></td><td class='diff-marker'> </td><td style="background: #eee; color:black; font-size: smaller;"><div><p>We introduced the idea of our project to Prof. Matičič and wanted to know if it could be applicable for the treatment of chronic hepatitis C. We proposed the idea of treating this disease with a combination of the standard therapeutic <b>interferon-alpha</b> and <b>hepatocyte growth factor</b> that would potentially reverse the long term effects of infection on progression to life threatening conditions such as liver cirrhosis and liver cancer that happen in up to 40% of untreated patients or patients unsuccessfully treated with the currently recommended standard of care medications. Her consideration was that something like this has never been done before and so it would be a complete novelty in treating hepatitis C and in her opinion it holds much promise for the future. She also wanted to know about the route of administration of the microcapsules. We considered two possibilities. The first would be a direct application to the liver. She told us this might be possible and that she could organize a meeting with an intervention radiologist, specializing in liver procedures, with whom we made arrangements to discuss this matter further. The other possibility which we considered for administration was to inject the microcapsules into the peritoneal cavity, which could accommodate a larger volume of microcapsules as a mimic of an artificial organ. It turns out intraperitoneal application might be suboptimal because the concentration of therapeutic in the liver would probably be lower.</p></div></td></tr>
<tr><td class='diff-marker'>-</td><td style="background: #ffa; color:black; font-size: smaller;"><div><p>Since we were interested in the perception of this type of therapy by patients, we composed a questionnaire on our project which she reviewed and distributed among her patients during her outpatient clinic duties. </p></div></td><td class='diff-marker'>+</td><td style="background: #cfc; color:black; font-size: smaller;"><div><p>Since we were interested in the perception of this type of therapy by patients, we composed a questionnaire on our project<ins class="diffchange diffchange-inline">, </ins>which she reviewed and distributed among her patients during her outpatient clinic duties. </p></div></td></tr>
<tr><td class='diff-marker'> </td><td style="background: #eee; color:black; font-size: smaller;"><div><div style="clear:both;"></div></div></td><td class='diff-marker'> </td><td style="background: #eee; color:black; font-size: smaller;"><div><div style="clear:both;"></div></div></td></tr>
<tr><td class='diff-marker'> </td><td style="background: #eee; color:black; font-size: smaller;"></td><td class='diff-marker'> </td><td style="background: #eee; color:black; font-size: smaller;"></td></tr>
</table>UrbanBhttp://2012.igem.org/wiki/index.php?title=Team:Slovenia/SocietyMedicalDoctors&diff=280672&oldid=prevDusanv at 02:04, 26 October 20122012-10-26T02:04:12Z<p></p>
<table style="background-color: white; color:black;">
<col class='diff-marker' />
<col class='diff-content' />
<col class='diff-marker' />
<col class='diff-content' />
<tr valign='top'>
<td colspan='2' style="background-color: white; color:black;">← Older revision</td>
<td colspan='2' style="background-color: white; color:black;">Revision as of 02:04, 26 October 2012</td>
</tr><tr><td colspan="2" class="diff-lineno">Line 465:</td>
<td colspan="2" class="diff-lineno">Line 465:</td></tr>
<tr><td class='diff-marker'> </td><td style="background: #eee; color:black; font-size: smaller;"></td><td class='diff-marker'> </td><td style="background: #eee; color:black; font-size: smaller;"></td></tr>
<tr><td class='diff-marker'> </td><td style="background: #eee; color:black; font-size: smaller;"><div></p><p></div></td><td class='diff-marker'> </td><td style="background: #eee; color:black; font-size: smaller;"><div></p><p></div></td></tr>
<tr><td class='diff-marker'>-</td><td style="background: #ffa; color:black; font-size: smaller;"><div>The discussion panel with <b>Prof. Dragica Smrke</b> took place at <b>the Department of Traumatology at the University Medical Centre Ljubljana</b> on the 15th of July 2012. The panel consisted of student team members, advisers and Prof. Dragica Smrke, who is <b>the head of the Department of Surgical Infections at the University Medical Centre Ljubljana</b> (Figure 2). She <del class="diffchange diffchange-inline">specialises </del>in treating chronic skin wounds and bone fractures that are not healing properly. </p></div></td><td class='diff-marker'>+</td><td style="background: #cfc; color:black; font-size: smaller;"><div>The discussion panel with <b>Prof. Dragica Smrke</b> took place at <b>the Department of Traumatology at the University Medical Centre Ljubljana</b> on the 15th of July 2012. The panel consisted of student team members, advisers and Prof. Dragica Smrke, who is <b>the head of the Department of Surgical Infections at the University Medical Centre Ljubljana</b> (Figure 2). She <ins class="diffchange diffchange-inline">specializes </ins>in treating chronic skin wounds and bone fractures that are not healing properly. </p></div></td></tr>
<tr><td class='diff-marker'>-</td><td style="background: #ffa; color:black; font-size: smaller;"><div><p>We presented the basic idea of our project and were interested if she thought that it was applicable to her area of specialty. There were two possible cases where we imagined it could be used, one is in the <b>therapy of bone fractures</b> that are not healing properly and the other is <b> chronic skin wound healing</b>. For the purpose of bone healing, microcapsules with therapeutic cells could be delivered at the site of the fracture and could support the formation of new bone tissue. The medical students in our team proposed to use bone morphogenetic protein factors (BMPs), of which she was <del class="diffchange diffchange-inline">sceptical</del>. She informed us that although these biological drugs are effective they are not in general use in clinical medicine, mainly because of their extremely high price. If our delivery system solved this problem this could represent a therapeutic application with great potential in the future. Prof. Smrke thought we could put our system to a much better use in the healing of chronic skin wounds which are extremely common in her everyday medical practice. An advantage to this approach is the ease of applying the microcapsules to the wounded tissue and a proposed collaboration on <i>in vivo</i> testing. The conclusion of our meeting was that this application could be a good way to improve chronic wound healing. </p></div></td><td class='diff-marker'>+</td><td style="background: #cfc; color:black; font-size: smaller;"><div><p>We presented the basic idea of our project and were interested if she thought that it was applicable to her area of specialty. There were two possible cases where we imagined it could be used, one is in the <b>therapy of bone fractures</b> that are not healing properly and the other is <b> chronic skin wound healing</b>. For the purpose of bone healing, microcapsules with therapeutic cells could be delivered at the site of the fracture and could support the formation of new bone tissue. The medical students in our team proposed to use bone morphogenetic protein factors (BMPs), of which she was <ins class="diffchange diffchange-inline">skeptical</ins>. She informed us that although these biological drugs are effective they are not in general use in clinical medicine, mainly because of their extremely high price. If our delivery system solved this problem this could represent a therapeutic application with great potential in the future. Prof. Smrke thought we could put our system to a much better use in the healing of chronic skin wounds which are extremely common in her everyday medical practice. An advantage to this approach is the ease of applying the microcapsules to the wounded tissue and a proposed collaboration on <i>in vivo</i> testing. The conclusion of our meeting was that this application could be a good way to improve chronic wound healing. </p></div></td></tr>
<tr><td class='diff-marker'> </td><td style="background: #eee; color:black; font-size: smaller;"><div><div style="clear:both;"></div></div></td><td class='diff-marker'> </td><td style="background: #eee; color:black; font-size: smaller;"><div><div style="clear:both;"></div></div></td></tr>
<tr><td class='diff-marker'> </td><td style="background: #eee; color:black; font-size: smaller;"></td><td class='diff-marker'> </td><td style="background: #eee; color:black; font-size: smaller;"></td></tr>
<tr><td colspan="2" class="diff-lineno">Line 482:</td>
<td colspan="2" class="diff-lineno">Line 482:</td></tr>
<tr><td class='diff-marker'> </td><td style="background: #eee; color:black; font-size: smaller;"><div>The meeting with <b>Prof. Mojca Matičič, head of the Department for Viral Hepatitis</b>, took place in the conference room at the <b>Clinic for Infectious Diseases and Febrile Illnesses, University Medical Centre Ljubljana</b> on the 17th of July 2012. The panel consisted of student team members, advisers and Prof. Mojca Matičič (Figure 3). She is <b>a specialist in infectious diseases and internal medicine</b> and her main area of expertise is clinical management of patients with <b>chronic hepatitis B or C</b>. </p></div></td><td class='diff-marker'> </td><td style="background: #eee; color:black; font-size: smaller;"><div>The meeting with <b>Prof. Mojca Matičič, head of the Department for Viral Hepatitis</b>, took place in the conference room at the <b>Clinic for Infectious Diseases and Febrile Illnesses, University Medical Centre Ljubljana</b> on the 17th of July 2012. The panel consisted of student team members, advisers and Prof. Mojca Matičič (Figure 3). She is <b>a specialist in infectious diseases and internal medicine</b> and her main area of expertise is clinical management of patients with <b>chronic hepatitis B or C</b>. </p></div></td></tr>
<tr><td class='diff-marker'> </td><td style="background: #eee; color:black; font-size: smaller;"></td><td class='diff-marker'> </td><td style="background: #eee; color:black; font-size: smaller;"></td></tr>
<tr><td class='diff-marker'>-</td><td style="background: #ffa; color:black; font-size: smaller;"><div><p>We introduced the idea of our project to Prof. Matičič and wanted to know if it could be applicable for the treatment of chronic hepatitis C. We proposed the idea of treating this disease with a combination of the standard therapeutic <b>interferon-alpha</b> and <b>hepatocyte growth factor</b> that would potentially reverse the long term effects of infection on progression to life threatening conditions such as liver cirrhosis and liver cancer that happen in up to 40% of untreated patients or patients unsuccessfully treated with the currently recommended standard of care medications. Her consideration was that something like this has never been done before and so it would be a complete novelty in treating hepatitis C and in her opinion it holds much promise for the future. She also wanted to know about the route of administration of the microcapsules. We considered two possibilities. The first would be a direct application to the liver. She told us this might be possible and that she could organize a meeting with an intervention radiologist, <del class="diffchange diffchange-inline">specialising </del>in liver procedures, with whom we made arrangements to discuss this matter further. The other possibility which we considered for administration was to inject the microcapsules into the peritoneal cavity, which could accommodate a larger volume of microcapsules as a mimic of an artificial organ. It turns out intraperitoneal application might be suboptimal because the concentration of therapeutic in the liver would probably be lower.</p></div></td><td class='diff-marker'>+</td><td style="background: #cfc; color:black; font-size: smaller;"><div><p>We introduced the idea of our project to Prof. Matičič and wanted to know if it could be applicable for the treatment of chronic hepatitis C. We proposed the idea of treating this disease with a combination of the standard therapeutic <b>interferon-alpha</b> and <b>hepatocyte growth factor</b> that would potentially reverse the long term effects of infection on progression to life threatening conditions such as liver cirrhosis and liver cancer that happen in up to 40% of untreated patients or patients unsuccessfully treated with the currently recommended standard of care medications. Her consideration was that something like this has never been done before and so it would be a complete novelty in treating hepatitis C and in her opinion it holds much promise for the future. She also wanted to know about the route of administration of the microcapsules. We considered two possibilities. The first would be a direct application to the liver. She told us this might be possible and that she could organize a meeting with an intervention radiologist, <ins class="diffchange diffchange-inline">specializing </ins>in liver procedures, with whom we made arrangements to discuss this matter further. The other possibility which we considered for administration was to inject the microcapsules into the peritoneal cavity, which could accommodate a larger volume of microcapsules as a mimic of an artificial organ. It turns out intraperitoneal application might be suboptimal because the concentration of therapeutic in the liver would probably be lower.</p></div></td></tr>
<tr><td class='diff-marker'> </td><td style="background: #eee; color:black; font-size: smaller;"><div><p>Since we were interested in the perception of this type of therapy by patients, we composed a questionnaire on our project which she reviewed and distributed among her patients during her outpatient clinic duties. </p></div></td><td class='diff-marker'> </td><td style="background: #eee; color:black; font-size: smaller;"><div><p>Since we were interested in the perception of this type of therapy by patients, we composed a questionnaire on our project which she reviewed and distributed among her patients during her outpatient clinic duties. </p></div></td></tr>
<tr><td class='diff-marker'> </td><td style="background: #eee; color:black; font-size: smaller;"><div><div style="clear:both;"></div></div></td><td class='diff-marker'> </td><td style="background: #eee; color:black; font-size: smaller;"><div><div style="clear:both;"></div></div></td></tr>
<tr><td colspan="2" class="diff-lineno">Line 526:</td>
<td colspan="2" class="diff-lineno">Line 526:</td></tr>
<tr><td class='diff-marker'> </td><td style="background: #eee; color:black; font-size: smaller;"><div></table></div></td><td class='diff-marker'> </td><td style="background: #eee; color:black; font-size: smaller;"><div></table></div></td></tr>
<tr><td class='diff-marker'> </td><td style="background: #eee; color:black; font-size: smaller;"><div></p><p></div></td><td class='diff-marker'> </td><td style="background: #eee; color:black; font-size: smaller;"><div></p><p></div></td></tr>
<tr><td class='diff-marker'>-</td><td style="background: #ffa; color:black; font-size: smaller;"><div>With respect to the treatment of hepatitis C we thought of three approaches: percutaneus application of capsules into the liver parenchyma, delivery into the peritoneal cavity or delivery via the interventional radiology approach through the portal vein or hepatic artery, a procedure which we discussed with <b>radiologist Peter Popovič, MD, Msc, teaching assistant. </b> Mr. Popovič is the head of the <b>Department for abdominal radiology</b> (Figure 5) at the Institute of Radiology and specializes in <b>hepatic interventional radiology</b>. We discussed the following approach: a radiologist introduces a catheter into the femoral artery and proceeds via the aorta to the hepatic artery where he injects the suspension of our cells into the blood. The capsules then travel through the arterial tree, getting stuck inside arterioles and capillaries of the liver, remaining there and producing our drug of choice. We got very excited as he went on to say that injecting capsules <b>into the hepatic artery would most likely be possible</b>. He explained that his team carries out these procedures on a daily basis, injecting microspheres (approximately the same size as our capsules) with attached chemoterapeutics into the hepatic artery to target malignant <del class="diffchange diffchange-inline">tumours </del>located in the liver parenchyma. To our fear that the capsules would block the blood flow to a significant portion of the liver parenchyma he responded with the fact that the liver gets the majority (80%) of nutrients and oxygen via the portal vein. He added that with the appropriate number of capsules a very small number of vessels would be blocked therefore <b>all of the tissue would be perfused because of collaterals</b>. This led us to our next question about the delivery to an ishemic muscle or the myocardium for <b>the treatment of ishemic heart disease or peripheral arterial disease</b>. Again he responded that an interventional radiology approach may be feasible. Mr. Popovič also mentioned that this approach could be tested on pigs, as mice are too small. He invited us to stay in touch for potential testing of this type of delivery with our microcapsules. Before the meeting we were concerned about not being able to deliver the capsules to the appropriate sites with ease, this meeting, however, filled us with renewed excitement. </p></div></td><td class='diff-marker'>+</td><td style="background: #cfc; color:black; font-size: smaller;"><div>With respect to the treatment of hepatitis C we thought of three approaches: percutaneus application of capsules into the liver parenchyma, delivery into the peritoneal cavity or delivery via the interventional radiology approach through the portal vein or hepatic artery, a procedure which we discussed with <b>radiologist Peter Popovič, MD, Msc, teaching assistant. </b> Mr. Popovič is the head of the <b>Department for abdominal radiology</b> (Figure 5) at the Institute of Radiology and specializes in <b>hepatic interventional radiology</b>. We discussed the following approach: a radiologist introduces a catheter into the femoral artery and proceeds via the aorta to the hepatic artery where he injects the suspension of our cells into the blood. The capsules then travel through the arterial tree, getting stuck inside arterioles and capillaries of the liver, remaining there and producing our drug of choice. We got very excited as he went on to say that injecting capsules <b>into the hepatic artery would most likely be possible</b>. He explained that his team carries out these procedures on a daily basis, injecting microspheres (approximately the same size as our capsules) with attached chemoterapeutics into the hepatic artery to target malignant <ins class="diffchange diffchange-inline">tumors </ins>located in the liver parenchyma. To our fear that the capsules would block the blood flow to a significant portion of the liver parenchyma he responded with the fact that the liver gets the majority (80%) of nutrients and oxygen via the portal vein. He added that with the appropriate number of capsules a very small number of vessels would be blocked therefore <b>all of the tissue would be perfused because of collaterals</b>. This led us to our next question about the delivery to an ishemic muscle or the myocardium for <b>the treatment of ishemic heart disease or peripheral arterial disease</b>. Again he responded that an interventional radiology approach may be feasible. Mr. Popovič also mentioned that this approach could be tested on pigs, as mice are too small. He invited us to stay in touch for potential testing of this type of delivery with our microcapsules. Before the meeting we were concerned about not being able to deliver the capsules to the appropriate sites with ease, this meeting, however, filled us with renewed excitement. </p></div></td></tr>
<tr><td class='diff-marker'> </td><td style="background: #eee; color:black; font-size: smaller;"><div> </div></td><td class='diff-marker'> </td><td style="background: #eee; color:black; font-size: smaller;"><div> </div></td></tr>
<tr><td class='diff-marker'> </td><td style="background: #eee; color:black; font-size: smaller;"><div><p>In summary, all physicians we contacted thought that the proposed approach offers many advantages and that it would definitely be worthwhile to test it <i>in vivo</i>. </p></div></td><td class='diff-marker'> </td><td style="background: #eee; color:black; font-size: smaller;"><div><p>In summary, all physicians we contacted thought that the proposed approach offers many advantages and that it would definitely be worthwhile to test it <i>in vivo</i>. </p></div></td></tr>
</table>Dusanvhttp://2012.igem.org/wiki/index.php?title=Team:Slovenia/SocietyMedicalDoctors&diff=280663&oldid=prevDusanv at 02:02, 26 October 20122012-10-26T02:02:40Z<p></p>
<table style="background-color: white; color:black;">
<col class='diff-marker' />
<col class='diff-content' />
<col class='diff-marker' />
<col class='diff-content' />
<tr valign='top'>
<td colspan='2' style="background-color: white; color:black;">← Older revision</td>
<td colspan='2' style="background-color: white; color:black;">Revision as of 02:02, 26 October 2012</td>
</tr><tr><td colspan="2" class="diff-lineno">Line 445:</td>
<td colspan="2" class="diff-lineno">Line 445:</td></tr>
<tr><td class='diff-marker'> </td><td style="background: #eee; color:black; font-size: smaller;"><div><tr class="summary"></div></td><td class='diff-marker'> </td><td style="background: #eee; color:black; font-size: smaller;"><div><tr class="summary"></div></td></tr>
<tr><td class='diff-marker'> </td><td style="background: #eee; color:black; font-size: smaller;"><div><td class="summary"></div></td><td class='diff-marker'> </td><td style="background: #eee; color:black; font-size: smaller;"><div><td class="summary"></div></td></tr>
<tr><td class='diff-marker'>-</td><td style="background: #ffa; color:black; font-size: smaller;"><div>We felt that the potential use of our <del class="diffchange diffchange-inline">inovation </del>should be <del class="diffchange diffchange-inline">disscused </del>with medical professionals and patients as they are the target population which could directly benefit from our idea. All physicians to whom we spoke expressed enthusiasm for this application of synthetic biology and assessed that the devised therapy would be attractive for many different diseases. </p></div></td><td class='diff-marker'>+</td><td style="background: #cfc; color:black; font-size: smaller;"><div>We felt that the potential use of our <ins class="diffchange diffchange-inline">innovation </ins>should be <ins class="diffchange diffchange-inline">discussed </ins>with medical professionals and patients as they are the target population which could directly benefit from our idea. All physicians to whom we spoke expressed enthusiasm for this application of synthetic biology and assessed that the devised therapy would be attractive for many different diseases. </p></div></td></tr>
<tr><td class='diff-marker'> </td><td style="background: #eee; color:black; font-size: smaller;"><div><p>We held discussion panels about our project with Prof. Dragica Smrke, MD, PhD, a surgeon; Prof. Mojca Matičič, MD, PhD, an infectologist specializing in hepatitis; Prof. Zlatko Fras, MD, PhD, a cardiologist; and Peter Popovič, MD, Msc, an interventional radiologist (all from the University Medical Centre Ljubljana and Medical Faculty, University of Ljubljana). Each of them contributed their opinion from a different medical viewpoint. </p></div></td><td class='diff-marker'> </td><td style="background: #eee; color:black; font-size: smaller;"><div><p>We held discussion panels about our project with Prof. Dragica Smrke, MD, PhD, a surgeon; Prof. Mojca Matičič, MD, PhD, an infectologist specializing in hepatitis; Prof. Zlatko Fras, MD, PhD, a cardiologist; and Peter Popovič, MD, Msc, an interventional radiologist (all from the University Medical Centre Ljubljana and Medical Faculty, University of Ljubljana). Each of them contributed their opinion from a different medical viewpoint. </p></div></td></tr>
<tr><td class='diff-marker'> </td><td style="background: #eee; color:black; font-size: smaller;"><div></td></div></td><td class='diff-marker'> </td><td style="background: #eee; color:black; font-size: smaller;"><div></td></div></td></tr>
</table>Dusanvhttp://2012.igem.org/wiki/index.php?title=Team:Slovenia/SocietyMedicalDoctors&diff=280289&oldid=prevDusanv at 00:01, 26 October 20122012-10-26T00:01:13Z<p></p>
<table style="background-color: white; color:black;">
<col class='diff-marker' />
<col class='diff-content' />
<col class='diff-marker' />
<col class='diff-content' />
<tr valign='top'>
<td colspan='2' style="background-color: white; color:black;">← Older revision</td>
<td colspan='2' style="background-color: white; color:black;">Revision as of 00:01, 26 October 2012</td>
</tr><tr><td colspan="2" class="diff-lineno">Line 400:</td>
<td colspan="2" class="diff-lineno">Line 400:</td></tr>
<tr><td class='diff-marker'> </td><td style="background: #eee; color:black; font-size: smaller;"><div> <li><a href='https://2012.igem.org/Team:Slovenia/Team'><span>Team members</span></a></li></div></td><td class='diff-marker'> </td><td style="background: #eee; color:black; font-size: smaller;"><div> <li><a href='https://2012.igem.org/Team:Slovenia/Team'><span>Team members</span></a></li></div></td></tr>
<tr><td class='diff-marker'> </td><td style="background: #eee; color:black; font-size: smaller;"><div> <li><a href='https://2012.igem.org/Team:Slovenia/TeamAttributions'><span>Attributions</span></a></li></div></td><td class='diff-marker'> </td><td style="background: #eee; color:black; font-size: smaller;"><div> <li><a href='https://2012.igem.org/Team:Slovenia/TeamAttributions'><span>Attributions</span></a></li></div></td></tr>
<tr><td colspan="2"> </td><td class='diff-marker'>+</td><td style="background: #cfc; color:black; font-size: smaller;"><div><ins style="color: red; font-weight: bold; text-decoration: none;"> <li><a href='https://2012.igem.org/Team:Slovenia/TeamCollaborations'><table class="newtable"><tr class="newtable"><td class="newtable"><span>Collaborations</span></td><td class="newtable"><img style="margin-right:-20px;" width="25px" src="https://static.igem.org/mediawiki/2012/e/ee/Svn12_hp_new.png"></img></td></tr></table></a></li></ins></div></td></tr>
<tr><td class='diff-marker'> </td><td style="background: #eee; color:black; font-size: smaller;"><div> <li><a href='https://2012.igem.org/Team:Slovenia/TeamGallery'><span>Gallery</span></a></li> </div></td><td class='diff-marker'> </td><td style="background: #eee; color:black; font-size: smaller;"><div> <li><a href='https://2012.igem.org/Team:Slovenia/TeamGallery'><span>Gallery</span></a></li> </div></td></tr>
<tr><td class='diff-marker'> </td><td style="background: #eee; color:black; font-size: smaller;"><div> <li><a href='https://2012.igem.org/Team:Slovenia/TeamSponsors'><span>Sponsors</span></a></li> </div></td><td class='diff-marker'> </td><td style="background: #eee; color:black; font-size: smaller;"><div> <li><a href='https://2012.igem.org/Team:Slovenia/TeamSponsors'><span>Sponsors</span></a></li> </div></td></tr>
</table>Dusanvhttp://2012.igem.org/wiki/index.php?title=Team:Slovenia/SocietyMedicalDoctors&diff=279132&oldid=prevStrazkosann at 17:38, 25 October 20122012-10-25T17:38:59Z<p></p>
<table style="background-color: white; color:black;">
<col class='diff-marker' />
<col class='diff-content' />
<col class='diff-marker' />
<col class='diff-content' />
<tr valign='top'>
<td colspan='2' style="background-color: white; color:black;">← Older revision</td>
<td colspan='2' style="background-color: white; color:black;">Revision as of 17:38, 25 October 2012</td>
</tr><tr><td colspan="2" class="diff-lineno">Line 214:</td>
<td colspan="2" class="diff-lineno">Line 214:</td></tr>
<tr><td class='diff-marker'> </td><td style="background: #eee; color:black; font-size: smaller;"><div>#cssmenu ul li > ul li{display:block; list-style:inside none; padding:0; margin:0; position:relative;} </div></td><td class='diff-marker'> </td><td style="background: #eee; color:black; font-size: smaller;"><div>#cssmenu ul li > ul li{display:block; list-style:inside none; padding:0; margin:0; position:relative;} </div></td></tr>
<tr><td class='diff-marker'> </td><td style="background: #eee; color:black; font-size: smaller;"><div>#cssmenu ul li > ul li a{ outline:none; display:block; position:relative; margin:0; padding:8px 20px; font:10pt Arial, Helvetica, sans-serif; color:#fff; text-decoration:none; text-shadow:1px 1px 0 rgba(0,0,0, 0.5); } </div></td><td class='diff-marker'> </td><td style="background: #eee; color:black; font-size: smaller;"><div>#cssmenu ul li > ul li a{ outline:none; display:block; position:relative; margin:0; padding:8px 20px; font:10pt Arial, Helvetica, sans-serif; color:#fff; text-decoration:none; text-shadow:1px 1px 0 rgba(0,0,0, 0.5); } </div></td></tr>
<tr><td colspan="2"> </td><td class='diff-marker'>+</td><td style="background: #cfc; color:black; font-size: smaller;"><div><ins style="color: red; font-weight: bold; text-decoration: none;">#cssmenu ul li > ul li a table tr td span{ outline:none; display:block; position:relative; margin:0; padding:0px 0px; font:10pt Arial, Helvetica, sans-serif; color:#fff; text-decoration:none; text-shadow:1px 1px 0 rgba(0,0,0, 0.5); } </ins></div></td></tr>
<tr><td class='diff-marker'> </td><td style="background: #eee; color:black; font-size: smaller;"><div>#cssmenu, #cssmenu > ul > li > ul > li a:hover</div></td><td class='diff-marker'> </td><td style="background: #eee; color:black; font-size: smaller;"><div>#cssmenu, #cssmenu > ul > li > ul > li a:hover</div></td></tr>
<tr><td class='diff-marker'> </td><td style="background: #eee; color:black; font-size: smaller;"><div>{ background:#043A6B; </div></td><td class='diff-marker'> </td><td style="background: #eee; color:black; font-size: smaller;"><div>{ background:#043A6B; </div></td></tr>
<tr><td colspan="2" class="diff-lineno">Line 229:</td>
<td colspan="2" class="diff-lineno">Line 230:</td></tr>
<tr><td class='diff-marker'> </td><td style="background: #eee; color:black; font-size: smaller;"><div>#cssmenu > ul > li > a:hover{background:#0C5DA5;} </div></td><td class='diff-marker'> </td><td style="background: #eee; color:black; font-size: smaller;"><div>#cssmenu > ul > li > a:hover{background:#0C5DA5;} </div></td></tr>
<tr><td class='diff-marker'> </td><td style="background: #eee; color:black; font-size: smaller;"><div>/* end CSS navigation menu (blue) */</div></td><td class='diff-marker'> </td><td style="background: #eee; color:black; font-size: smaller;"><div>/* end CSS navigation menu (blue) */</div></td></tr>
<tr><td colspan="2"> </td><td class='diff-marker'>+</td><td style="background: #cfc; color:black; font-size: smaller;"><div><ins style="color: red; font-weight: bold; text-decoration: none;"></ins></div></td></tr>
<tr><td colspan="2"> </td><td class='diff-marker'>+</td><td style="background: #cfc; color:black; font-size: smaller;"><div><ins style="color: red; font-weight: bold; text-decoration: none;">/*new table start*/</ins></div></td></tr>
<tr><td colspan="2"> </td><td class='diff-marker'>+</td><td style="background: #cfc; color:black; font-size: smaller;"><div><ins style="color: red; font-weight: bold; text-decoration: none;">table.newtable {background-color:transparent;}</ins></div></td></tr>
<tr><td colspan="2"> </td><td class='diff-marker'>+</td><td style="background: #cfc; color:black; font-size: smaller;"><div><ins style="color: red; font-weight: bold; text-decoration: none;">td.newtable, th.newtable {background-color:transparent;}</ins></div></td></tr>
<tr><td colspan="2"> </td><td class='diff-marker'>+</td><td style="background: #cfc; color:black; font-size: smaller;"><div><ins style="color: red; font-weight: bold; text-decoration: none;">thead.newtable{ }</ins></div></td></tr>
<tr><td colspan="2"> </td><td class='diff-marker'>+</td><td style="background: #cfc; color:black; font-size: smaller;"><div><ins style="color: red; font-weight: bold; text-decoration: none;">tbody .newtable{}</ins></div></td></tr>
<tr><td colspan="2"> </td><td class='diff-marker'>+</td><td style="background: #cfc; color:black; font-size: smaller;"><div><ins style="color: red; font-weight: bold; text-decoration: none;">/*new table*/</ins></div></td></tr>
<tr><td class='diff-marker'> </td><td style="background: #eee; color:black; font-size: smaller;"></td><td class='diff-marker'> </td><td style="background: #eee; color:black; font-size: smaller;"></td></tr>
<tr><td class='diff-marker'> </td><td style="background: #eee; color:black; font-size: smaller;"></td><td class='diff-marker'> </td><td style="background: #eee; color:black; font-size: smaller;"></td></tr>
<tr><td colspan="2" class="diff-lineno">Line 306:</td>
<td colspan="2" class="diff-lineno">Line 314:</td></tr>
<tr><td class='diff-marker'> </td><td style="background: #eee; color:black; font-size: smaller;"><div><body></div></td><td class='diff-marker'> </td><td style="background: #eee; color:black; font-size: smaller;"><div><body></div></td></tr>
<tr><td class='diff-marker'> </td><td style="background: #eee; color:black; font-size: smaller;"><div><div id="banner"></div></td><td class='diff-marker'> </td><td style="background: #eee; color:black; font-size: smaller;"><div><div id="banner"></div></td></tr>
<tr><td class='diff-marker'>-</td><td style="background: #ffa; color:black; font-size: smaller;"><div><del style="color: red; font-weight: bold; text-decoration: none;"><a style="position:absolute; top:0px; left:490px;" href="https://2012.igem.org/Main_Page"><b>iGEM 2012</b></a></del></div></td><td colspan="2"> </td></tr>
<tr><td class='diff-marker'> </td><td style="background: #eee; color:black; font-size: smaller;"><div></div></div></td><td class='diff-marker'> </td><td style="background: #eee; color:black; font-size: smaller;"><div></div></div></td></tr>
<tr><td class='diff-marker'> </td><td style="background: #eee; color:black; font-size: smaller;"></td><td class='diff-marker'> </td><td style="background: #eee; color:black; font-size: smaller;"></td></tr>
<tr><td colspan="2" class="diff-lineno">Line 329:</td>
<td colspan="2" class="diff-lineno">Line 336:</td></tr>
<tr><td class='diff-marker'> </td><td style="background: #eee; color:black; font-size: smaller;"><div> <li><a href='https://2012.igem.org/Team:Slovenia/TheSwitchDesignedTALregulators'><span>Designed TAL regulators</span></a></li></div></td><td class='diff-marker'> </td><td style="background: #eee; color:black; font-size: smaller;"><div> <li><a href='https://2012.igem.org/Team:Slovenia/TheSwitchDesignedTALregulators'><span>Designed TAL regulators</span></a></li></div></td></tr>
<tr><td class='diff-marker'> </td><td style="background: #eee; color:black; font-size: smaller;"><div> <li><a href='https://2012.igem.org/Team:Slovenia/TheSwitchMutualRepressorSwitch'><span>Mutual repressor switch</span></a></li> </div></td><td class='diff-marker'> </td><td style="background: #eee; color:black; font-size: smaller;"><div> <li><a href='https://2012.igem.org/Team:Slovenia/TheSwitchMutualRepressorSwitch'><span>Mutual repressor switch</span></a></li> </div></td></tr>
<tr><td class='diff-marker'>-</td><td style="background: #ffa; color:black; font-size: smaller;"><div> <li><a href='https://2012.igem.org/Team:Slovenia/TheSwitchPositiveFeedbackLoopSwitch'><span>Positive feedback loop switch</span></a></li> </div></td><td class='diff-marker'>+</td><td style="background: #cfc; color:black; font-size: smaller;"><div> <li><a href='https://2012.igem.org/Team:Slovenia/TheSwitchPositiveFeedbackLoopSwitch'<ins class="diffchange diffchange-inline">><table class="newtable"><tr class="newtable"><td class="newtable"</ins>><span>Positive feedback loop switch</span<ins class="diffchange diffchange-inline">></td><td class="newtable"><img style="margin-right:-15px;" width="25px" src="https://static.igem.org/mediawiki/2012/e/ee/Svn12_hp_new.png"></img></td></tr></table></a></li></ins></div></td></tr>
<tr><td colspan="2"> </td><td class='diff-marker'>+</td><td style="background: #cfc; color:black; font-size: smaller;"><div><ins class="diffchange diffchange-inline"> <li><a href='https://2012.igem.org/Team:Slovenia/TheSwitchControls'><table class="newtable"><tr class="newtable"><td class="newtable"><span>Controls</span></td><td class="newtable"><img style="margin-right:-81px;" width="25px" src="https://static.igem.org/mediawiki/2012/e/ee/Svn12_hp_new.png"></img></td></tr></table</ins>></a></li> </div></td></tr>
<tr><td class='diff-marker'> </td><td style="background: #eee; color:black; font-size: smaller;"><div> </ul></div></td><td class='diff-marker'> </td><td style="background: #eee; color:black; font-size: smaller;"><div> </ul></div></td></tr>
<tr><td class='diff-marker'> </td><td style="background: #eee; color:black; font-size: smaller;"><div> </li></div></td><td class='diff-marker'> </td><td style="background: #eee; color:black; font-size: smaller;"><div> </li></div></td></tr>
<tr><td colspan="2" class="diff-lineno">Line 337:</td>
<td colspan="2" class="diff-lineno">Line 345:</td></tr>
<tr><td class='diff-marker'> </td><td style="background: #eee; color:black; font-size: smaller;"><div> <li><a href='https://2012.igem.org/Team:Slovenia/SafetyMechanismsEscapeTag'><span>Escape tag</span></a></li> </div></td><td class='diff-marker'> </td><td style="background: #eee; color:black; font-size: smaller;"><div> <li><a href='https://2012.igem.org/Team:Slovenia/SafetyMechanismsEscapeTag'><span>Escape tag</span></a></li> </div></td></tr>
<tr><td class='diff-marker'> </td><td style="background: #eee; color:black; font-size: smaller;"><div> <li><a href='https://2012.igem.org/Team:Slovenia/SafetyMechanismsTermination'><span>Termination</span></a></li> </div></td><td class='diff-marker'> </td><td style="background: #eee; color:black; font-size: smaller;"><div> <li><a href='https://2012.igem.org/Team:Slovenia/SafetyMechanismsTermination'><span>Termination</span></a></li> </div></td></tr>
<tr><td class='diff-marker'>-</td><td style="background: #ffa; color:black; font-size: smaller;"><div><del class="diffchange diffchange-inline"> </del><li><a href='https://2012.igem.org/Team:Slovenia/SafetyMechanismsMicrocapsuleDegradation'><span>Microcapsule degradation</span></a></li> </div></td><td class='diff-marker'>+</td><td style="background: #cfc; color:black; font-size: smaller;"><div><ins class="diffchange diffchange-inline"> </ins><li><a href='https://2012.igem.org/Team:Slovenia/SafetyMechanismsMicrocapsuleDegradation'<ins class="diffchange diffchange-inline">><table class="newtable"><tr class="newtable"><td class="newtable"</ins>><span>Microcapsule degradation</span<ins class="diffchange diffchange-inline">></td><td class="newtable"><img style="margin-right:-15px;" width="25px" src="https://static.igem.org/mediawiki/2012/e/ee/Svn12_hp_new.png"></img></td></tr></table</ins>></a></li> </div></td></tr>
<tr><td class='diff-marker'> </td><td style="background: #eee; color:black; font-size: smaller;"><div> </ul></div></td><td class='diff-marker'> </td><td style="background: #eee; color:black; font-size: smaller;"><div> </ul></div></td></tr>
<tr><td class='diff-marker'> </td><td style="background: #eee; color:black; font-size: smaller;"><div> </li></div></td><td class='diff-marker'> </td><td style="background: #eee; color:black; font-size: smaller;"><div> </li></div></td></tr>
<tr><td colspan="2" class="diff-lineno">Line 345:</td>
<td colspan="2" class="diff-lineno">Line 353:</td></tr>
<tr><td class='diff-marker'> </td><td style="background: #eee; color:black; font-size: smaller;"><div> <li><a href='https://2012.igem.org/Team:Slovenia/ImplementationHepatitisC'><span>Hepatitis C</span></a></li></div></td><td class='diff-marker'> </td><td style="background: #eee; color:black; font-size: smaller;"><div> <li><a href='https://2012.igem.org/Team:Slovenia/ImplementationHepatitisC'><span>Hepatitis C</span></a></li></div></td></tr>
<tr><td class='diff-marker'> </td><td style="background: #eee; color:black; font-size: smaller;"><div> <li><a href='https://2012.igem.org/Team:Slovenia/ImplementationIschaemicHeartDisease'><span>Ischaemic heart disease</span></a></li> </div></td><td class='diff-marker'> </td><td style="background: #eee; color:black; font-size: smaller;"><div> <li><a href='https://2012.igem.org/Team:Slovenia/ImplementationIschaemicHeartDisease'><span>Ischaemic heart disease</span></a></li> </div></td></tr>
<tr><td colspan="2"> </td><td class='diff-marker'>+</td><td style="background: #cfc; color:black; font-size: smaller;"><div><ins style="color: red; font-weight: bold; text-decoration: none;"> <li><a href='https://2012.igem.org/Team:Slovenia/ImplementationImpact'><table class="newtable"><tr class="newtable"><td class="newtable"><span>Impact</span></td><td class="newtable"><img style="margin-right:-86px;" width="25px" src="https://static.igem.org/mediawiki/2012/e/ee/Svn12_hp_new.png"></img></td></tr></table></a></li> </ins></div></td></tr>
<tr><td class='diff-marker'> </td><td style="background: #eee; color:black; font-size: smaller;"><div> </div></td><td class='diff-marker'> </td><td style="background: #eee; color:black; font-size: smaller;"><div> </div></td></tr>
<tr><td class='diff-marker'> </td><td style="background: #eee; color:black; font-size: smaller;"><div> </ul></div></td><td class='diff-marker'> </td><td style="background: #eee; color:black; font-size: smaller;"><div> </ul></div></td></tr>
<tr><td colspan="2" class="diff-lineno">Line 352:</td>
<td colspan="2" class="diff-lineno">Line 361:</td></tr>
<tr><td class='diff-marker'> </td><td style="background: #eee; color:black; font-size: smaller;"><div> <ul></div></td><td class='diff-marker'> </td><td style="background: #eee; color:black; font-size: smaller;"><div> <ul></div></td></tr>
<tr><td class='diff-marker'> </td><td style="background: #eee; color:black; font-size: smaller;"><div> <li><a href='https://2012.igem.org/Team:Slovenia/Modeling'><span>Overview</span></a></li></div></td><td class='diff-marker'> </td><td style="background: #eee; color:black; font-size: smaller;"><div> <li><a href='https://2012.igem.org/Team:Slovenia/Modeling'><span>Overview</span></a></li></div></td></tr>
<tr><td class='diff-marker'>-</td><td style="background: #ffa; color:black; font-size: smaller;"><div><del class="diffchange diffchange-inline"> </del><li><a href='https://2012.igem.org/Team:Slovenia/ModelingPK'><span>Pharmacokinetics</span></a></li></div></td><td class='diff-marker'>+</td><td style="background: #cfc; color:black; font-size: smaller;"><div><ins class="diffchange diffchange-inline"> </ins><li><a href='https://2012.igem.org/Team:Slovenia/ModelingPK'<ins class="diffchange diffchange-inline">><table class="newtable"><tr class="newtable"><td class="newtable"</ins>><span>Pharmacokinetics</span<ins class="diffchange diffchange-inline">></td><td class="newtable"><img style="margin-right:-15px;" width="25px" src="https://static.igem.org/mediawiki/2012/e/ee/Svn12_hp_new.png"></img></td></tr></table</ins>></a></li> <ins class="diffchange diffchange-inline"> </ins></div></td></tr>
<tr><td class='diff-marker'> </td><td style="background: #eee; color:black; font-size: smaller;"><div> <li><a href='https://2012.igem.org/Team:Slovenia/ModelingMethods'><span>Modeling methods</span></a></li></div></td><td class='diff-marker'> </td><td style="background: #eee; color:black; font-size: smaller;"><div> <li><a href='https://2012.igem.org/Team:Slovenia/ModelingMethods'><span>Modeling methods</span></a></li></div></td></tr>
<tr><td class='diff-marker'> </td><td style="background: #eee; color:black; font-size: smaller;"><div> <li><a href='https://2012.igem.org/Team:Slovenia/ModelingMutualRepressorSwitch'><span>Mutual repressor switch</span></a></li></div></td><td class='diff-marker'> </td><td style="background: #eee; color:black; font-size: smaller;"><div> <li><a href='https://2012.igem.org/Team:Slovenia/ModelingMutualRepressorSwitch'><span>Mutual repressor switch</span></a></li></div></td></tr>
<tr><td class='diff-marker'> </td><td style="background: #eee; color:black; font-size: smaller;"><div> <li><a href='https://2012.igem.org/Team:Slovenia/ModelingPositiveFeedbackLoopSwitch'><span>Positive feedback loop switch</span></a></li> </div></td><td class='diff-marker'> </td><td style="background: #eee; color:black; font-size: smaller;"><div> <li><a href='https://2012.igem.org/Team:Slovenia/ModelingPositiveFeedbackLoopSwitch'><span>Positive feedback loop switch</span></a></li> </div></td></tr>
<tr><td class='diff-marker'>-</td><td style="background: #ffa; color:black; font-size: smaller;"><div> <li><a href='https://2012.igem.org/Team:Slovenia/ModelingQuantitativeModel'><span><del class="diffchange diffchange-inline">Quantitative and stability </del>model</span></a></li> </div></td><td class='diff-marker'>+</td><td style="background: #cfc; color:black; font-size: smaller;"><div> <li><a href='https://2012.igem.org/Team:Slovenia/ModelingQuantitativeModel'<ins class="diffchange diffchange-inline">><table class="newtable"><tr class="newtable"><td class="newtable"</ins>><span><ins class="diffchange diffchange-inline">Experimental </ins>model</span<ins class="diffchange diffchange-inline">></td><td class="newtable"><img style="margin-right:-15px;" width="25px" src="https://static.igem.org/mediawiki/2012/e/ee/Svn12_hp_new.png"></img></td></tr></table</ins>></a></li> </div></td></tr>
<tr><td class='diff-marker'>-</td><td style="background: #ffa; color:black; font-size: smaller;"><div><del class="diffchange diffchange-inline"> </del><li><a href='https://2012.igem.org/Team:Slovenia/ModelingInteractiveSimulations'><span>Interactive simulations</span></a></li> <del class="diffchange diffchange-inline"> </del></div></td><td class='diff-marker'>+</td><td style="background: #cfc; color:black; font-size: smaller;"><div><ins class="diffchange diffchange-inline"> </ins><li><a href='https://2012.igem.org/Team:Slovenia/ModelingInteractiveSimulations'<ins class="diffchange diffchange-inline">><table class="newtable"><tr class="newtable"><td class="newtable"</ins>><span>Interactive simulations</span<ins class="diffchange diffchange-inline">></td><td class="newtable"><img style="margin-right:-15px;" width="25px" src="https://static.igem.org/mediawiki/2012/e/ee/Svn12_hp_new.png"></img></td></tr></table</ins>></a></li> <ins class="diffchange diffchange-inline"> </ins></div></td></tr>
<tr><td class='diff-marker'> </td><td style="background: #eee; color:black; font-size: smaller;"><div> </ul></div></td><td class='diff-marker'> </td><td style="background: #eee; color:black; font-size: smaller;"><div> </ul></div></td></tr>
<tr><td class='diff-marker'> </td><td style="background: #eee; color:black; font-size: smaller;"><div> </li></div></td><td class='diff-marker'> </td><td style="background: #eee; color:black; font-size: smaller;"><div> </li></div></td></tr>
<tr><td colspan="2" class="diff-lineno">Line 368:</td>
<td colspan="2" class="diff-lineno">Line 377:</td></tr>
<tr><td class='diff-marker'> </td><td style="background: #eee; color:black; font-size: smaller;"><div> <ul></div></td><td class='diff-marker'> </td><td style="background: #eee; color:black; font-size: smaller;"><div> <ul></div></td></tr>
<tr><td class='diff-marker'> </td><td style="background: #eee; color:black; font-size: smaller;"><div> <li><a href='https://2012.igem.org/Team:Slovenia/Notebook'><span>Experimental methods</span></a></li></div></td><td class='diff-marker'> </td><td style="background: #eee; color:black; font-size: smaller;"><div> <li><a href='https://2012.igem.org/Team:Slovenia/Notebook'><span>Experimental methods</span></a></li></div></td></tr>
<tr><td class='diff-marker'>-</td><td style="background: #ffa; color:black; font-size: smaller;"><div><del class="diffchange diffchange-inline"> </del><li><a href='https://2012.igem.org/Team:Slovenia/NotebookLablog'><span>Lablog</span></a></li></div></td><td class='diff-marker'>+</td><td style="background: #cfc; color:black; font-size: smaller;"><div><ins class="diffchange diffchange-inline"> </ins><li><a href='https://2012.igem.org/Team:Slovenia/NotebookLablog'<ins class="diffchange diffchange-inline">><table class="newtable"><tr class="newtable"><td class="newtable"</ins>><span>Lablog</span<ins class="diffchange diffchange-inline">></td><td class="newtable"><img style="margin-right:-90px;" width="25px" src="https://static.igem.org/mediawiki/2012/e/ee/Svn12_hp_new.png"></img></td></tr></table</ins>></a></li> <ins class="diffchange diffchange-inline"> </ins></div></td></tr>
<tr><td class='diff-marker'> </td><td style="background: #eee; color:black; font-size: smaller;"><div> <li><a href='https://2012.igem.org/Team:Slovenia/NotebookLabSafety'><span>Lab safety</span></a></li> </div></td><td class='diff-marker'> </td><td style="background: #eee; color:black; font-size: smaller;"><div> <li><a href='https://2012.igem.org/Team:Slovenia/NotebookLabSafety'><span>Lab safety</span></a></li> </div></td></tr>
<tr><td class='diff-marker'> </td><td style="background: #eee; color:black; font-size: smaller;"><div> </ul></div></td><td class='diff-marker'> </td><td style="background: #eee; color:black; font-size: smaller;"><div> </ul></div></td></tr>
<tr><td colspan="2" class="diff-lineno">Line 398:</td>
<td colspan="2" class="diff-lineno">Line 407:</td></tr>
<tr><td class='diff-marker'> </td><td style="background: #eee; color:black; font-size: smaller;"><div> </div></div></td><td class='diff-marker'> </td><td style="background: #eee; color:black; font-size: smaller;"><div> </div></div></td></tr>
<tr><td class='diff-marker'> </td><td style="background: #eee; color:black; font-size: smaller;"><div><!-- end main menu --></div></td><td class='diff-marker'> </td><td style="background: #eee; color:black; font-size: smaller;"><div><!-- end main menu --></div></td></tr>
<tr><td colspan="2"> </td><td class='diff-marker'>+</td><td style="background: #cfc; color:black; font-size: smaller;"><div><ins style="color: red; font-weight: bold; text-decoration: none;"></ins></div></td></tr>
<tr><td colspan="2"> </td><td class='diff-marker'>+</td><td style="background: #cfc; color:black; font-size: smaller;"><div><ins style="color: red; font-weight: bold; text-decoration: none;"></ins></div></td></tr>
<tr><td colspan="2"> </td><td class='diff-marker'>+</td><td style="background: #cfc; color:black; font-size: smaller;"><div><ins style="color: red; font-weight: bold; text-decoration: none;"></ins></div></td></tr>
<tr><td class='diff-marker'> </td><td style="background: #eee; color:black; font-size: smaller;"></td><td class='diff-marker'> </td><td style="background: #eee; color:black; font-size: smaller;"></td></tr>
<tr><td class='diff-marker'> </td><td style="background: #eee; color:black; font-size: smaller;"><div></div> <!-- end menu --></div></td><td class='diff-marker'> </td><td style="background: #eee; color:black; font-size: smaller;"><div></div> <!-- end menu --></div></td></tr>
<tr><td colspan="2" class="diff-lineno">Line 403:</td>
<td colspan="2" class="diff-lineno">Line 415:</td></tr>
<tr><td class='diff-marker'> </td><td style="background: #eee; color:black; font-size: smaller;"><div><div id="main"></div></td><td class='diff-marker'> </td><td style="background: #eee; color:black; font-size: smaller;"><div><div id="main"></div></td></tr>
<tr><td class='diff-marker'> </td><td style="background: #eee; color:black; font-size: smaller;"><div><br/></div></td><td class='diff-marker'> </td><td style="background: #eee; color:black; font-size: smaller;"><div><br/></div></td></tr>
<tr><td colspan="2"> </td><td class='diff-marker'>+</td><td style="background: #cfc; color:black; font-size: smaller;"><div><ins style="color: red; font-weight: bold; text-decoration: none;"></ins></div></td></tr>
<tr><td colspan="2"> </td><td class='diff-marker'>+</td><td style="background: #cfc; color:black; font-size: smaller;"><div><ins style="color: red; font-weight: bold; text-decoration: none;"><!-- dummy link na bannerju --></ins></div></td></tr>
<tr><td colspan="2"> </td><td class='diff-marker'>+</td><td style="background: #cfc; color:black; font-size: smaller;"><div><ins style="color: red; font-weight: bold; text-decoration: none;"><a href="https://2012.igem.org/Main_Page"></ins></div></td></tr>
<tr><td colspan="2"> </td><td class='diff-marker'>+</td><td style="background: #cfc; color:black; font-size: smaller;"><div><ins style="color: red; font-weight: bold; text-decoration: none;"><div id="dummy" style="background-color:white; position:absolute; left:870px; top:25px; width:115px; height:80px; z-index:100; opacity:0.0;"></ins></div></td></tr>
<tr><td colspan="2"> </td><td class='diff-marker'>+</td><td style="background: #cfc; color:black; font-size: smaller;"><div><ins style="color: red; font-weight: bold; text-decoration: none;"></div></ins></div></td></tr>
<tr><td colspan="2"> </td><td class='diff-marker'>+</td><td style="background: #cfc; color:black; font-size: smaller;"><div><ins style="color: red; font-weight: bold; text-decoration: none;"></a></ins></div></td></tr>
<tr><td class='diff-marker'> </td><td style="background: #eee; color:black; font-size: smaller;"></td><td class='diff-marker'> </td><td style="background: #eee; color:black; font-size: smaller;"></td></tr>
<tr><td class='diff-marker'> </td><td style="background: #eee; color:black; font-size: smaller;"><div><!-- VSEBINA OD TU DALJE --></div></td><td class='diff-marker'> </td><td style="background: #eee; color:black; font-size: smaller;"><div><!-- VSEBINA OD TU DALJE --></div></td></tr>
</table>Strazkosannhttp://2012.igem.org/wiki/index.php?title=Team:Slovenia/SocietyMedicalDoctors&diff=269059&oldid=prevUrbanB at 08:34, 12 October 20122012-10-12T08:34:50Z<p></p>
<table style="background-color: white; color:black;">
<col class='diff-marker' />
<col class='diff-content' />
<col class='diff-marker' />
<col class='diff-content' />
<tr valign='top'>
<td colspan='2' style="background-color: white; color:black;">← Older revision</td>
<td colspan='2' style="background-color: white; color:black;">Revision as of 08:34, 12 October 2012</td>
</tr><tr><td colspan="2" class="diff-lineno">Line 507:</td>
<td colspan="2" class="diff-lineno">Line 507:</td></tr>
<tr><td class='diff-marker'> </td><td style="background: #eee; color:black; font-size: smaller;"><div></table></div></td><td class='diff-marker'> </td><td style="background: #eee; color:black; font-size: smaller;"><div></table></div></td></tr>
<tr><td class='diff-marker'> </td><td style="background: #eee; color:black; font-size: smaller;"><div></p><p></div></td><td class='diff-marker'> </td><td style="background: #eee; color:black; font-size: smaller;"><div></p><p></div></td></tr>
<tr><td class='diff-marker'>-</td><td style="background: #ffa; color:black; font-size: smaller;"><div>With respect to the treatment of hepatitis C we thought of three approaches: percutaneus application of capsules into the liver parenchyma, delivery into the peritoneal cavity or delivery via the interventional radiology approach through the portal vein or hepatic artery, a procedure which we discussed with <b>radiologist Peter Popovič, MD, Msc, teaching assistant. </b> Mr. Popovič is the head of the <b>Department for abdominal radiology</b> (Figure 5) at the Institute of Radiology and specializes in <b>hepatic interventional radiology</b>. We discussed the following approach: a radiologist introduces a catheter into the femoral artery and proceeds via the <del class="diffchange diffchange-inline">thoracic artery </del>to the hepatic artery where he injects the suspension of our cells into the blood. The capsules then travel through the arterial tree, getting stuck inside arterioles and capillaries of the liver, remaining there and producing our drug of choice. We got very excited as he went on to say that injecting capsules <b>into the hepatic artery would most likely be possible</b>. He explained that his team carries out these procedures on a daily basis, injecting microspheres (approximately the same size as our capsules) with attached chemoterapeutics into the hepatic artery to target malignant tumours located in the liver parenchyma. To our fear that the capsules would block the blood flow to a significant portion of the liver parenchyma he responded with the fact that the liver gets the majority (80%) of nutrients and oxygen via the portal vein. He added that with the appropriate number of capsules a very small number of vessels would be blocked therefore <b>all of the tissue would be perfused because of collaterals</b>. This led us to our next question about the delivery to an ishemic muscle or the myocardium for <b>the treatment of ishemic heart disease or peripheral arterial disease</b>. Again he responded that an interventional radiology approach may be feasible. Mr. Popovič also mentioned that this approach could be tested on pigs, as mice are too small. He invited us to stay in touch for potential testing of this type of delivery with our microcapsules. Before the meeting we were concerned about not being able to deliver the capsules to the appropriate sites with ease, this meeting, however, filled us with renewed excitement. </p></div></td><td class='diff-marker'>+</td><td style="background: #cfc; color:black; font-size: smaller;"><div>With respect to the treatment of hepatitis C we thought of three approaches: percutaneus application of capsules into the liver parenchyma, delivery into the peritoneal cavity or delivery via the interventional radiology approach through the portal vein or hepatic artery, a procedure which we discussed with <b>radiologist Peter Popovič, MD, Msc, teaching assistant. </b> Mr. Popovič is the head of the <b>Department for abdominal radiology</b> (Figure 5) at the Institute of Radiology and specializes in <b>hepatic interventional radiology</b>. We discussed the following approach: a radiologist introduces a catheter into the femoral artery and proceeds via the <ins class="diffchange diffchange-inline">aorta </ins>to the hepatic artery where he injects the suspension of our cells into the blood. The capsules then travel through the arterial tree, getting stuck inside arterioles and capillaries of the liver, remaining there and producing our drug of choice. We got very excited as he went on to say that injecting capsules <b>into the hepatic artery would most likely be possible</b>. He explained that his team carries out these procedures on a daily basis, injecting microspheres (approximately the same size as our capsules) with attached chemoterapeutics into the hepatic artery to target malignant tumours located in the liver parenchyma. To our fear that the capsules would block the blood flow to a significant portion of the liver parenchyma he responded with the fact that the liver gets the majority (80%) of nutrients and oxygen via the portal vein. He added that with the appropriate number of capsules a very small number of vessels would be blocked therefore <b>all of the tissue would be perfused because of collaterals</b>. This led us to our next question about the delivery to an ishemic muscle or the myocardium for <b>the treatment of ishemic heart disease or peripheral arterial disease</b>. Again he responded that an interventional radiology approach may be feasible. Mr. Popovič also mentioned that this approach could be tested on pigs, as mice are too small. He invited us to stay in touch for potential testing of this type of delivery with our microcapsules. Before the meeting we were concerned about not being able to deliver the capsules to the appropriate sites with ease, this meeting, however, filled us with renewed excitement. </p></div></td></tr>
<tr><td class='diff-marker'> </td><td style="background: #eee; color:black; font-size: smaller;"><div> </div></td><td class='diff-marker'> </td><td style="background: #eee; color:black; font-size: smaller;"><div> </div></td></tr>
<tr><td class='diff-marker'> </td><td style="background: #eee; color:black; font-size: smaller;"><div><p>In summary, all physicians we contacted thought that the proposed approach offers many advantages and that it would definitely be worthwhile to test it <i>in vivo</i>. </p></div></td><td class='diff-marker'> </td><td style="background: #eee; color:black; font-size: smaller;"><div><p>In summary, all physicians we contacted thought that the proposed approach offers many advantages and that it would definitely be worthwhile to test it <i>in vivo</i>. </p></div></td></tr>
</table>UrbanBhttp://2012.igem.org/wiki/index.php?title=Team:Slovenia/SocietyMedicalDoctors&diff=212908&oldid=prevStrazkosann at 19:46, 26 September 20122012-09-26T19:46:33Z<p></p>
<table style="background-color: white; color:black;">
<col class='diff-marker' />
<col class='diff-content' />
<col class='diff-marker' />
<col class='diff-content' />
<tr valign='top'>
<td colspan='2' style="background-color: white; color:black;">← Older revision</td>
<td colspan='2' style="background-color: white; color:black;">Revision as of 19:46, 26 September 2012</td>
</tr><tr><td colspan="2" class="diff-lineno">Line 414:</td>
<td colspan="2" class="diff-lineno">Line 414:</td></tr>
<tr><td class='diff-marker'> </td><td style="background: #eee; color:black; font-size: smaller;"><div><tbody class="inliner"></div></td><td class='diff-marker'> </td><td style="background: #eee; color:black; font-size: smaller;"><div><tbody class="inliner"></div></td></tr>
<tr><td class='diff-marker'> </td><td style="background: #eee; color:black; font-size: smaller;"><div><tr class="inliner"><td class="inliner"><img class="inliner" src="https://static.igem.org/mediawiki/2012/8/81/Svn12_society_physicians_fig1.jpg"/></td></tr> </div></td><td class='diff-marker'> </td><td style="background: #eee; color:black; font-size: smaller;"><div><tr class="inliner"><td class="inliner"><img class="inliner" src="https://static.igem.org/mediawiki/2012/8/81/Svn12_society_physicians_fig1.jpg"/></td></tr> </div></td></tr>
<tr><td class='diff-marker'>-</td><td style="background: #ffa; color:black; font-size: smaller;"><div><tr class="inliner"><td class="inliner"><b>Figure 1.</b> <b> Medical team at the Division of Internal Medicine of the University Medical Centre Ljubljana, Slovenia.</b> </div></td><td class='diff-marker'>+</td><td style="background: #cfc; color:black; font-size: smaller;"><div><tr class="inliner"><td class="inliner<ins class="diffchange diffchange-inline">" style="text-align:justify;</ins>"><b>Figure 1.</b> <b> Medical team at the Division of Internal Medicine of the University Medical Centre Ljubljana, Slovenia.</b> </div></td></tr>
<tr><td class='diff-marker'> </td><td style="background: #eee; color:black; font-size: smaller;"><div>From the left: Petra Zupan, a registered nurse, Miran Brvar, MD, PhD, Assist. Prof., a specialist in internal medicine, Hikmer Badnjević, a nurse. </div></td><td class='diff-marker'> </td><td style="background: #eee; color:black; font-size: smaller;"><div>From the left: Petra Zupan, a registered nurse, Miran Brvar, MD, PhD, Assist. Prof., a specialist in internal medicine, Hikmer Badnjević, a nurse. </div></td></tr>
<tr><td class='diff-marker'> </td><td style="background: #eee; color:black; font-size: smaller;"><div></td></tr></div></td><td class='diff-marker'> </td><td style="background: #eee; color:black; font-size: smaller;"><div></td></tr></div></td></tr>
<tr><td colspan="2" class="diff-lineno">Line 439:</td>
<td colspan="2" class="diff-lineno">Line 439:</td></tr>
<tr><td class='diff-marker'> </td><td style="background: #eee; color:black; font-size: smaller;"><div><tbody class="inliner"></div></td><td class='diff-marker'> </td><td style="background: #eee; color:black; font-size: smaller;"><div><tbody class="inliner"></div></td></tr>
<tr><td class='diff-marker'> </td><td style="background: #eee; color:black; font-size: smaller;"><div><tr class="inliner"><td class="inliner"><img class="inliner" src="https://static.igem.org/mediawiki/2012/7/74/Svn12_society_physicians_fig2.jpg"/></td></tr> </div></td><td class='diff-marker'> </td><td style="background: #eee; color:black; font-size: smaller;"><div><tr class="inliner"><td class="inliner"><img class="inliner" src="https://static.igem.org/mediawiki/2012/7/74/Svn12_society_physicians_fig2.jpg"/></td></tr> </div></td></tr>
<tr><td class='diff-marker'>-</td><td style="background: #ffa; color:black; font-size: smaller;"><div><tr class="inliner"><td class="inliner"><b>Figure 2.</b> <b> Meeting with Prof. Dragica Smrke (first from the right) at the Department of Traumatology of the University Medical Centre Ljubljana.</b></div></td><td class='diff-marker'>+</td><td style="background: #cfc; color:black; font-size: smaller;"><div><tr class="inliner"><td class="inliner<ins class="diffchange diffchange-inline">" style="text-align:justify;</ins>"><b>Figure 2.</b> <b> Meeting with Prof. Dragica Smrke (first from the right) at the Department of Traumatology of the University Medical Centre Ljubljana.</b></div></td></tr>
<tr><td class='diff-marker'> </td><td style="background: #eee; color:black; font-size: smaller;"><div> </td></tr></div></td><td class='diff-marker'> </td><td style="background: #eee; color:black; font-size: smaller;"><div> </td></tr></div></td></tr>
<tr><td class='diff-marker'> </td><td style="background: #eee; color:black; font-size: smaller;"><div></tbody></div></td><td class='diff-marker'> </td><td style="background: #eee; color:black; font-size: smaller;"><div></tbody></div></td></tr>
<tr><td colspan="2" class="diff-lineno">Line 456:</td>
<td colspan="2" class="diff-lineno">Line 456:</td></tr>
<tr><td class='diff-marker'> </td><td style="background: #eee; color:black; font-size: smaller;"><div><tbody class="inliner"></div></td><td class='diff-marker'> </td><td style="background: #eee; color:black; font-size: smaller;"><div><tbody class="inliner"></div></td></tr>
<tr><td class='diff-marker'> </td><td style="background: #eee; color:black; font-size: smaller;"><div><tr class="inliner"><td class="inliner"><img class="inliner" src="https://static.igem.org/mediawiki/2012/8/8e/Svn12_society_physicians_fig3.jpg"/></td></tr> </div></td><td class='diff-marker'> </td><td style="background: #eee; color:black; font-size: smaller;"><div><tr class="inliner"><td class="inliner"><img class="inliner" src="https://static.igem.org/mediawiki/2012/8/8e/Svn12_society_physicians_fig3.jpg"/></td></tr> </div></td></tr>
<tr><td class='diff-marker'>-</td><td style="background: #ffa; color:black; font-size: smaller;"><div><tr class="inliner"><td class="inliner"><b>Figure 3.</b> <b> Meeting with Prof. Mojca Matičič (first from the left) at the Clinic for Infectious Diseases and Febrile Illnesses, University Medical Centre Ljubljana.</b></b></div></td><td class='diff-marker'>+</td><td style="background: #cfc; color:black; font-size: smaller;"><div><tr class="inliner"><td class="inliner<ins class="diffchange diffchange-inline">" style="text-align:justify;</ins>"><b>Figure 3.</b> <b> Meeting with Prof. Mojca Matičič (first from the left) at the Clinic for Infectious Diseases and Febrile Illnesses, University Medical Centre Ljubljana.</b></b></div></td></tr>
<tr><td class='diff-marker'> </td><td style="background: #eee; color:black; font-size: smaller;"><div> </td></tr></div></td><td class='diff-marker'> </td><td style="background: #eee; color:black; font-size: smaller;"><div> </td></tr></div></td></tr>
<tr><td class='diff-marker'> </td><td style="background: #eee; color:black; font-size: smaller;"><div></tbody></div></td><td class='diff-marker'> </td><td style="background: #eee; color:black; font-size: smaller;"><div></tbody></div></td></tr>
<tr><td colspan="2" class="diff-lineno">Line 474:</td>
<td colspan="2" class="diff-lineno">Line 474:</td></tr>
<tr><td class='diff-marker'> </td><td style="background: #eee; color:black; font-size: smaller;"><div><tbody class="inliner"></div></td><td class='diff-marker'> </td><td style="background: #eee; color:black; font-size: smaller;"><div><tbody class="inliner"></div></td></tr>
<tr><td class='diff-marker'> </td><td style="background: #eee; color:black; font-size: smaller;"><div><tr class="inliner"><td class="inliner"><img class="inliner" src="https://static.igem.org/mediawiki/2012/5/5c/Svn12_society_physicians_fig4.jpg"/></td></tr> </div></td><td class='diff-marker'> </td><td style="background: #eee; color:black; font-size: smaller;"><div><tr class="inliner"><td class="inliner"><img class="inliner" src="https://static.igem.org/mediawiki/2012/5/5c/Svn12_society_physicians_fig4.jpg"/></td></tr> </div></td></tr>
<tr><td class='diff-marker'>-</td><td style="background: #ffa; color:black; font-size: smaller;"><div><tr class="inliner"><td class="inliner"></div></td><td class='diff-marker'>+</td><td style="background: #cfc; color:black; font-size: smaller;"><div><tr class="inliner"><td class="inliner<ins class="diffchange diffchange-inline">" style="text-align:justify;</ins>"></div></td></tr>
<tr><td class='diff-marker'> </td><td style="background: #eee; color:black; font-size: smaller;"><div><b>Figure 4.</b> </div></td><td class='diff-marker'> </td><td style="background: #eee; color:black; font-size: smaller;"><div><b>Figure 4.</b> </div></td></tr>
<tr><td class='diff-marker'> </td><td style="background: #eee; color:black; font-size: smaller;"><div><b>Meeting with Prof. Zlatko Fras (second from the right) at the Division of internal medicine, University Medical Centre Ljubljana.</b></div></td><td class='diff-marker'> </td><td style="background: #eee; color:black; font-size: smaller;"><div><b>Meeting with Prof. Zlatko Fras (second from the right) at the Division of internal medicine, University Medical Centre Ljubljana.</b></div></td></tr>
<tr><td colspan="2" class="diff-lineno">Line 499:</td>
<td colspan="2" class="diff-lineno">Line 499:</td></tr>
<tr><td class='diff-marker'> </td><td style="background: #eee; color:black; font-size: smaller;"><div><tbody class="inliner"></div></td><td class='diff-marker'> </td><td style="background: #eee; color:black; font-size: smaller;"><div><tbody class="inliner"></div></td></tr>
<tr><td class='diff-marker'> </td><td style="background: #eee; color:black; font-size: smaller;"><div><tr class="inliner"><td class="inliner"><img class="inliner" src="https://static.igem.org/mediawiki/2012/6/61/Svn12_society_physicians_fig5.jpg"/></td></tr> </div></td><td class='diff-marker'> </td><td style="background: #eee; color:black; font-size: smaller;"><div><tr class="inliner"><td class="inliner"><img class="inliner" src="https://static.igem.org/mediawiki/2012/6/61/Svn12_society_physicians_fig5.jpg"/></td></tr> </div></td></tr>
<tr><td class='diff-marker'>-</td><td style="background: #ffa; color:black; font-size: smaller;"><div><tr class="inliner"><td class="inliner"></div></td><td class='diff-marker'>+</td><td style="background: #cfc; color:black; font-size: smaller;"><div><tr class="inliner"><td class="inliner<ins class="diffchange diffchange-inline">" style="text-align:justify;</ins>"></div></td></tr>
<tr><td class='diff-marker'> </td><td style="background: #eee; color:black; font-size: smaller;"><div><b>Figure 5.</b> </div></td><td class='diff-marker'> </td><td style="background: #eee; color:black; font-size: smaller;"><div><b>Figure 5.</b> </div></td></tr>
<tr><td class='diff-marker'> </td><td style="background: #eee; color:black; font-size: smaller;"><div><b>Peter Popovič, MD, from the Institute of Radiology, University Medical Centre Ljubljana.</b></div></td><td class='diff-marker'> </td><td style="background: #eee; color:black; font-size: smaller;"><div><b>Peter Popovič, MD, from the Institute of Radiology, University Medical Centre Ljubljana.</b></div></td></tr>
</table>Strazkosannhttp://2012.igem.org/wiki/index.php?title=Team:Slovenia/SocietyMedicalDoctors&diff=212803&oldid=prevStrazkosann at 19:44, 26 September 20122012-09-26T19:44:16Z<p></p>
<table style="background-color: white; color:black;">
<col class='diff-marker' />
<col class='diff-content' />
<col class='diff-marker' />
<col class='diff-content' />
<tr valign='top'>
<td colspan='2' style="background-color: white; color:black;">← Older revision</td>
<td colspan='2' style="background-color: white; color:black;">Revision as of 19:44, 26 September 2012</td>
</tr><tr><td colspan="2" class="diff-lineno">Line 488:</td>
<td colspan="2" class="diff-lineno">Line 488:</td></tr>
<tr><td class='diff-marker'> </td><td style="background: #eee; color:black; font-size: smaller;"></td><td class='diff-marker'> </td><td style="background: #eee; color:black; font-size: smaller;"></td></tr>
<tr><td class='diff-marker'> </td><td style="background: #eee; color:black; font-size: smaller;"></td><td class='diff-marker'> </td><td style="background: #eee; color:black; font-size: smaller;"></td></tr>
<tr><td class='diff-marker'>-</td><td style="background: #ffa; color:black; font-size: smaller;"><div><del style="color: red; font-weight: bold; text-decoration: none;"></br> </del></div></td><td colspan="2"> </td></tr>
<tr><td class='diff-marker'> </td><td style="background: #eee; color:black; font-size: smaller;"><div><p>During the course of our project we often asked ourselves what the best way to introduce microcapsules with engineered synthetic devices into the body would be. The ideal type of administration would have to be: </p></div></td><td class='diff-marker'> </td><td style="background: #eee; color:black; font-size: smaller;"><div><p>During the course of our project we often asked ourselves what the best way to introduce microcapsules with engineered synthetic devices into the body would be. The ideal type of administration would have to be: </p></div></td></tr>
<tr><td class='diff-marker'> </td><td style="background: #eee; color:black; font-size: smaller;"><div><ol type="a"></div></td><td class='diff-marker'> </td><td style="background: #eee; color:black; font-size: smaller;"><div><ol type="a"></div></td></tr>
</table>Strazkosann